{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:47:57Z","timestamp":1793843277644,"version":"4.6.1"},"reference-count":244,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01618-1","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:55:55Z","timestamp":1764136555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-coding RNAs in Parkinson's Disease: Pathogenesis, Exosomes, and Therapeutic Horizons"],"prefix":"10.1007","volume":"46","author":[{"given":"Niloufar","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zivari Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansure","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrang","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Noureddini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Rafiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sepehr","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Eshraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8270-3276","authenticated-orcid":false,"given":"Tahereh","family":"Mazoochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-8281","authenticated-orcid":false,"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"1618_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071574","author":"U Ala","year":"2020","unstructured":"Ala U (2020) Competing endogenous RNAs, non-coding RNAs and diseases: an intertwined story. Cells. https:\/\/doi.org\/10.3390\/cells9071574","journal-title":"Cells"},{"issue":"1","key":"1618_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10571-025-01578-6","volume":"45","author":"ER Asl","year":"2025","unstructured":"Asl ER, Hosseini SE, Tahmasebi F, Bolandi N, Barati S (2025) MiR-124 and MiR-155 as therapeutic targets in microglia-mediated inflammation in multiple sclerosis. Cell Mol Neurobiol 45(1):63. https:\/\/doi.org\/10.1007\/s10571-025-01578-6","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"1618_CR3","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1111\/jcmm.14979","volume":"24","author":"M Baghi","year":"2020","unstructured":"Baghi M, Rostamian Delavar M, Yadegari E, Peymani M, Pozo D, Hossein Nasr-Esfahani M, Ghaedi K (2020) Modified level of miR-376a is associated with Parkinson\u2019s disease. J Cell Mol Med 24(4):2622\u20132634. https:\/\/doi.org\/10.1111\/jcmm.14979","journal-title":"J Cell Mol Med"},{"issue":"13","key":"1618_CR4","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1111\/jcmm.16612","volume":"25","author":"M Baghi","year":"2021","unstructured":"Baghi M, Yadegari E, Rostamian Delavar M, Peymani M, Ganjalikhani-Hakemi M, Salari M, Nasr-Esfahani MH, Megraw TL, Ghaedi K (2021) Mir-193b deregulation is associated with Parkinson\u2019s disease. J Cell Mol Med 25(13):6348\u20136360. https:\/\/doi.org\/10.1111\/jcmm.16612","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1618_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23530","volume":"38","author":"H Bao","year":"2024","unstructured":"Bao H, Zhang Q, Li Y, Nie C (2024) Circdlgap4 overexpression ameliorates neuronal injury in Parkinson\u2019s disease by binding to EIF4A3 and increasing HMGA2 expression. J Biochem Mol Toxicol 38(1):e23530. https:\/\/doi.org\/10.1002\/jbt.23530","journal-title":"J Biochem Mol Toxicol"},{"issue":"10423","key":"1618_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8","journal-title":"Lancet"},{"issue":"10291","key":"1618_CR7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303","journal-title":"Lancet"},{"key":"1618_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.599246","volume":"12","author":"LL Bu","year":"2020","unstructured":"Bu LL, Xie YY, Lin DY, Chen Y, Jing XN, Liang YR, Peng SD, Huang KX, Tao EX (2020) LncRNA-T199678 mitigates \u03b1-synuclein-induced dopaminergic neuron injury via miR-101-3p. Front Aging Neurosci 12:599246. https:\/\/doi.org\/10.3389\/fnagi.2020.599246","journal-title":"Front Aging Neurosci"},{"key":"1618_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ensci.2018.09.002","volume":"13","author":"E Caggiu","year":"2018","unstructured":"Caggiu E, Paulus K, Mameli G, Arru G, Sechi GP, Sechi LA (2018) Differential expression of miRNA 155 and miRNA 146a in Parkinson\u2019s disease patients. eNeurolSci 13:1\u20134. https:\/\/doi.org\/10.1016\/j.ensci.2018.09.002","journal-title":"eNeurolSci"},{"issue":"1","key":"1618_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13041-020-00656-8","volume":"13","author":"LJ Cai","year":"2020","unstructured":"Cai LJ, Tu L, Huang XM, Huang J, Qiu N, Xie GH, Liao JX, Du W, Zhang YY, Tian JY (2020) LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson\u2019s disease. Mol Brain 13(1):130. https:\/\/doi.org\/10.1186\/s13041-020-00656-8","journal-title":"Mol Brain"},{"key":"1618_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.07.019","volume":"388","author":"B Cao","year":"2018","unstructured":"Cao B, Wang T, Qu Q, Kang T, Yang Q (2018) Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson\u2019s disease via regulating miR-7\/NLRP3 pathway. Neuroscience 388:118\u2013127. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.07.019","journal-title":"Neuroscience"},{"issue":"8","key":"1618_CR12","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.18632\/aging.202837","volume":"13","author":"H Cao","year":"2021","unstructured":"Cao H, Han X, Jia Y, Zhang B (2021) Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson\u2019s disease model via targeting miR-124-3p mediated FSTL1\/NF-\u03baB axis. Aging (Albany NY) 13(8):11455\u201311469. https:\/\/doi.org\/10.18632\/aging.202837","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"1618_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11011-021-00869-3","volume":"37","author":"X Cao","year":"2022","unstructured":"Cao X, Guo J, Mochizuki H, Xu D, Zhang T, Han H, Ma T, Qi M, He J (2022) Circular RNA circ_0070441 regulates MPP+-triggered neurotoxic effect in SH-SY5Y cells via miR-626\/IRS2 axis. Metab Brain Dis 37(2):513\u2013524. https:\/\/doi.org\/10.1007\/s11011-021-00869-3","journal-title":"Metab Brain Dis"},{"key":"1618_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101771","volume":"49","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S, Patravale V, Salwa DY, Tang BZ (2023) Exosome nanovesicles: a potential carrier for therapeutic delivery. Nano Today 49:101771. https:\/\/doi.org\/10.1016\/j.nantod.2023.101771","journal-title":"Nano Today"},{"issue":"23","key":"1618_CR17","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","volume":"187","author":"LL Chen","year":"2024","unstructured":"Chen LL, Kim VN (2024) Small and long non-coding RNAs: past, present, and future. Cell 187(23):6451\u20136485. https:\/\/doi.org\/10.1016\/j.cell.2024.10.024","journal-title":"Cell"},{"key":"1618_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","volume":"9","author":"Y Chen","year":"2017","unstructured":"Chen Y, Gao C, Sun Q, Pan H, Huang P, Ding J, Chen S (2017) Microrna-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson\u2019s disease. Front Aging Neurosci 9:232. https:\/\/doi.org\/10.3389\/fnagi.2017.00232","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1618_CR20","first-page":"563","volume":"10","author":"Q Chen","year":"2018","unstructured":"Chen Q, Huang X, Li R (2018) LncRNA MALAT1\/miR-205-5p axis regulates MPP(+)-induced cell apoptosis in MN9D cells by directly targeting LRRK2. Am J Transl Res 10(2):563\u2013572","journal-title":"Am J Transl Res"},{"issue":"5","key":"1618_CR16","first-page":"4735","volume":"12","author":"L Chen","year":"2019","unstructured":"Chen L, Gan L, Zhou H-Y, Liang J-H (2019) Protective effects of miR-19b in Parkinson\u2019s disease by inhibiting the activation of iNOS through negative regulation of p38 signaling pathways. Int J Clin Exp Med 12(5):4735\u20134744","journal-title":"Int J Clin Exp Med"},{"key":"1618_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.646817","volume":"12","author":"M Chen","year":"2021","unstructured":"Chen M, Peng L, Gong P, Zheng X, Sun T, Zhang X, Huo J (2021a) Baicalein induces mitochondrial autophagy to prevent Parkinson\u2019s disease in rats via miR-30b and the SIRT1\/AMPK\/mTOR pathway. Front Neurol 12:646817. https:\/\/doi.org\/10.3389\/fneur.2021.646817","journal-title":"Front Neurol"},{"issue":"1","key":"1618_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/21655979.2021.1883279","volume":"12","author":"MY Chen","year":"2021","unstructured":"Chen MY, Fan K, Zhao LJ, Wei JM, Gao JX, Li ZF (2021b) Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson\u2019s disease. Bioengineered 12(1):708\u2013719. https:\/\/doi.org\/10.1080\/21655979.2021.1883279","journal-title":"Bioengineered"},{"issue":"1","key":"1618_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000518212","volume":"29","author":"C Chen","year":"2022","unstructured":"Chen C, Zhang S, Wei Y, Sun X (2022a) LncRNA RMST regulates neuronal apoptosis and inflammatory response via sponging miR-150-5p in Parkinson\u2019s disease. NeuroImmunoModulation 29(1):55\u201362. https:\/\/doi.org\/10.1159\/000518212","journal-title":"NeuroImmunoModulation"},{"key":"1618_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136638","volume":"782","author":"W Chen","year":"2022","unstructured":"Chen W, Hou C, Wang Y, Hong L, Wang F, Zhang J (2022b) Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson\u2019s disease by targeting miR-26a-5p\/DAPK1. Neurosci Lett 782:136638. https:\/\/doi.org\/10.1016\/j.neulet.2022.136638","journal-title":"Neurosci Lett"},{"key":"1618_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102430","volume":"56","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, Wang J, Li M, Fang J, Ding H, Meng J, Zhang J, Fang X, Liu H, Ma C, Chen C, Zhang W (2022) CircSV2b participates in oxidative stress regulation through miR-5107-5p-Foxk1-Akt1 axis in Parkinson\u2019s disease. Redox Biol 56:102430. https:\/\/doi.org\/10.1016\/j.redox.2022.102430","journal-title":"Redox Biol"},{"key":"1618_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fncel.2019.00399","volume":"13","author":"CC Chiu","year":"2019","unstructured":"Chiu CC, Yeh TH, Chen RS, Chen HC, Huang YZ, Weng YH, Cheng YC, Liu YC, Cheng AJ, Lu YC, Chen YJ, Lin YW, Hsu CC, Chen YL, Lu CS, Wang HL (2019) Upregulated expression of MicroRNA-204-5p leads to the death of dopaminergic cells by targeting DYRK1A-mediated apoptotic signaling cascade. Front Cell Neurosci 13:399. https:\/\/doi.org\/10.3389\/fncel.2019.00399","journal-title":"Front Cell Neurosci"},{"key":"1618_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ncrna.2025.01.004","volume":"11","author":"B Chodurska","year":"2025","unstructured":"Chodurska B, Kunej T (2025) Long non-coding RNAs in humans: classification, genomic organization and function. Noncoding RNA Res 11:313\u2013327. https:\/\/doi.org\/10.1016\/j.ncrna.2025.01.004","journal-title":"Noncoding RNA Res"},{"issue":"5696","key":"1618_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1105136","volume":"306","author":"Consortium EP","year":"2004","unstructured":"Consortium EP (2004) The ENCODE (ENCyclopedia Of DNA Elements) project. Science 306(5696):636\u2013640. https:\/\/doi.org\/10.1126\/science.1105136","journal-title":"Science"},{"key":"1618_CR27","doi-asserted-by":"publisher","unstructured":"Consortium EP, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, Kuehn MS, Taylor CM, Neph S, Koch CM, Asthana S, Malhotra A, Adzhubei I, Greenbaum JA, Andrews RM, Flicek P, Boyle PJ, Cao H, Carter NP, Clelland GK, Davis S, Day N, Dhami P, Dillon SC, Dorschner MO, Fiegler H, Giresi PG, Goldy J, Hawrylycz M, Haydock A, Humbert R, James KD, Johnson BE, Johnson EM, Frum TT, Rosenzweig ER, Karnani N, Lee K, Lefebvre GC, Navas PA, Neri F, Parker SC, Sabo PJ, Sandstrom R, Shafer A, Vetrie D, Weaver M, Wilcox S, Yu M, Collins FS, Dekker J, Lieb JD, Tullius TD, Crawford GE, Sunyaev S, Noble WS, Dunham I, Denoeud F, Reymond A, Kapranov P, Rozowsky J, Zheng D, Castelo R, Frankish A, Harrow J, Ghosh S, Sandelin A, Hofacker IL, Baertsch R, Keefe D, Dike S, Cheng J, Hirsch HA, Sekinger EA, Lagarde J, Abril JF, Shahab A, Flamm C, Fried C, Hackermuller J, Hertel J, Lindemeyer M, Missal K, Tanzer A, Washietl S, Korbel J, Emanuelsson O, Pedersen JS, Holroyd N, Taylor R, Swarbreck D, Matthews N, Dickson MC, Thomas DJ, Weirauch MT, Gilbert J, Drenkow J, Bell I, Zhao X, Srinivasan KG, Sung WK, Ooi HS, Chiu KP, Foissac S, Alioto T, Brent M, Pachter L, Tress ML, Valencia A, Choo SW, Choo CY, Ucla C, Manzano C, Wyss C, Cheung E, Clark TG, Brown JB, Ganesh M, Patel S, Tammana H, Chrast J, Henrichsen CN, Kai C, Kawai J, Nagalakshmi U, Wu J, Lian Z, Lian J, Newburger P, Zhang X, Bickel P, Mattick JS, Carninci P, Hayashizaki Y, Weissman S, Hubbard T, Myers RM, Rogers J, Stadler PF, Lowe TM, Wei CL, Ruan Y, Struhl K, Gerstein M, Antonarakis SE, Fu Y, Green ED, Karaoz U, Siepel A, Taylor J, Liefer LA, Wetterstrand KA, Good PJ, Feingold EA, Guyer MS, Cooper GM, Asimenos G, Dewey CN, Hou M, Nikolaev S, Montoya-Burgos JI, Loytynoja A, Whelan S, Pardi F, Massingham T, Huang H, Zhang NR, Holmes I, Mullikin JC, Ureta-Vidal A, Paten B, Seringhaus M, Church D, Rosenbloom K, Kent WJ, Stone EA, Program NCS, Baylor College of Medicine Human Genome Sequencing C, Washington University Genome Sequencing C, Broad I, Children's Hospital Oakland Research I, Batzoglou S, Goldman N, Hardison RC, Haussler D, Miller W, Sidow A, Trinklein ND, Zhang ZD, Barrera L, Stuart R, King DC, Ameur A, Enroth S, Bieda MC, Kim J, Bhinge AA, Jiang N, Liu J, Yao F, Vega VB, Lee CW, Ng P, Shahab A, Yang A, Moqtaderi Z, Zhu Z, Xu X, Squazzo S, Oberley MJ, Inman D, Singer MA, Richmond TA, Munn KJ, Rada-Iglesias A, Wallerman O, Komorowski J, Fowler JC, Couttet P, Bruce AW, Dovey OM, Ellis PD, Langford CF, Nix DA, Euskirchen G, Hartman S, Urban AE, Kraus P, Van Calcar S, Heintzman N, Kim TH, Wang K, Qu C, Hon G, Luna R, Glass CK, Rosenfeld MG, Aldred SF, Cooper SJ, Halees A, Lin JM, Shulha HP, Zhang X, Xu M, Haidar JN, Yu Y, Ruan Y, Iyer VR, Green RD, Wadelius C, Farnham PJ, Ren B, Harte RA, Hinrichs AS, Trumbower H, Clawson H, Hillman-Jackson J, Zweig AS, Smith K, Thakkapallayil A, Barber G, Kuhn RM, Karolchik D, Armengol L, Bird CP, de Bakker PI, Kern AD, Lopez-Bigas N, Martin JD, Stranger BE, Woodroffe A, Davydov E, Dimas A, Eyras E, Hallgrimsdottir IB, Huppert J, Zody MC, Abecasis GR, Estivill X, Bouffard GG, Guan X, Hansen NF, Idol JR, Maduro VV, Maskeri B, McDowell JC, Park M, Thomas PJ, Young AC, Blakesley RW, Muzny DM, Sodergren E, Wheeler DA, Worley KC, Jiang H, Weinstock GM, Gibbs RA, Graves T, Fulton R, Mardis ER, Wilson RK, Clamp M, Cuff J, Gnerre S, Jaffe DB, Chang JL, Lindblad-Toh K, Lander ES, Koriabine M, Nefedov M, Osoegawa K, Yoshinaga Y, Zhu B, de Jong PJ (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (7146):799\u2013816. https:\/\/doi.org\/10.1038\/nature05874","DOI":"10.1038\/nature05874"},{"issue":"3","key":"1618_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mds.27935","volume":"35","author":"M Cressatti","year":"2020","unstructured":"Cressatti M, Juwara L, Galindez JM, Velly AM, Nkurunziza ES, Marier S, Canie O, Gornistky M, Schipper HM (2020) Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson\u2019s disease. Mov Disord 35(3):468\u2013477. https:\/\/doi.org\/10.1002\/mds.27935","journal-title":"Mov Disord"},{"issue":"5","key":"1618_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molcel.2014.03.045","volume":"54","author":"R Denzler","year":"2014","unstructured":"Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M (2014) Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell 54(5):766\u2013776. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.045","journal-title":"Mol Cell"},{"issue":"6","key":"1618_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 38(6):613\u2013626. https:\/\/doi.org\/10.1016\/j.tig.2022.02.006","journal-title":"Trends Genet"},{"key":"1618_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cbi.2019.04.017","volume":"307","author":"XM Ding","year":"2019","unstructured":"Ding XM, Zhao LJ, Qiao HY, Wu SL, Wang XH (2019) Long non-coding RNA-p21 regulates MPP(+)-induced neuronal injury by targeting miR-625 and derepressing TRPM2 in SH-SY5Y cells. Chem Biol Interact 307:73\u201381. https:\/\/doi.org\/10.1016\/j.cbi.2019.04.017","journal-title":"Chem Biol Interact"},{"issue":"1","key":"1618_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcb.26170","volume":"119","author":"RF Dong","year":"2018","unstructured":"Dong RF, Zhang B, Tai LW, Liu HM, Shi FK, Liu NN (2018) The neuroprotective role of MiR-124-3p in a 6-hydroxydopamine-induced cell model of Parkinson\u2019s disease via the regulation of ANAX5. J Cell Biochem 119(1):269\u2013277. https:\/\/doi.org\/10.1002\/jcb.26170","journal-title":"J Cell Biochem"},{"issue":"7","key":"1618_CR33","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/abbs\/gmab055","volume":"53","author":"LI Dong","year":"2021","unstructured":"Dong LI, Zheng Y, Gao L, Luo X (2021) LncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease by impairing miR-374c-5p. Acta Biochim Biophys Sin (Shanghai) 53(7):870\u2013882. https:\/\/doi.org\/10.1093\/abbs\/gmab055","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1618_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116123","volume":"171","author":"H Dong","year":"2024","unstructured":"Dong H, Yan J, Huang P, Wang X, Zhang R, Zhang C, Wang W, Qian W, Zhou J, Zhao Y, Gao J, Zhang M, Ma X, Wang Z, Yi C, Zhang J, Chen W (2024) Mir-214-3p promotes the pathogenesis of Parkinson\u2019s disease by inhibiting autophagy. Biomed Pharmacother 171:116123. https:\/\/doi.org\/10.1016\/j.biopha.2024.116123","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1618_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41531-021-00265-9","volume":"8","author":"E Doxakis","year":"2022","unstructured":"Doxakis E (2022) Insights into the multifaceted role of circular RNAs: implications for Parkinson\u2019s disease pathogenesis and diagnosis. NPJ Parkinsons Dis 8(1):7. https:\/\/doi.org\/10.1038\/s41531-021-00265-9","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"1618_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jcp.30932","volume":"238","author":"A Elangovan","year":"2023","unstructured":"Elangovan A, Venkatesan D, Selvaraj P, Pasha MY, Babu HWS, Iyer M, Narayanasamy A, Subramaniam MD, Valsala Gopalakrishnan A, Kumar NS, Vellingiri B (2023) miRNA in Parkinson\u2019s disease: from pathogenesis to theranostic approaches. J Cell Physiol 238(2):329\u2013354. https:\/\/doi.org\/10.1002\/jcp.30932","journal-title":"J Cell Physiol"},{"issue":"1","key":"1618_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10571-025-01538-0","volume":"45","author":"A Esmaeili","year":"2025","unstructured":"Esmaeili A, Yazdanpanah N, Rezaei N (2025) LncRNAs orchestrating neuroinflammation: a comprehensive review. Cell Mol Neurobiol 45(1):21. https:\/\/doi.org\/10.1007\/s10571-025-01538-0","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"1618_CR38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ymthe.2019.08.005","volume":"28","author":"S Espinoza","year":"2020","unstructured":"Espinoza S, Scarpato M, Damiani D, Manago F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S (2020) SINEUP non-coding RNA targeting GDNF rescues motor deficits and neurodegeneration in a mouse model of Parkinson\u2019s disease. Mol Ther 28(2):642\u2013652. https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.005","journal-title":"Mol Ther"},{"key":"1618_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainresbull.2020.02.003","volume":"157","author":"Y Fan","year":"2020","unstructured":"Fan Y, Zhao X, Lu K, Cheng G (2020) LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease via ablating microRNA-125b-5p. Brain Res Bull 157:119\u2013127. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.02.003","journal-title":"Brain Res Bull"},{"issue":"2","key":"1618_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbrc.2019.11.102","volume":"522","author":"Z Feng","year":"2020","unstructured":"Feng Z, Zhang L, Wang S, Hong Q (2020) Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p\/CREB pathway in Parkinson\u2019s disease. Biochem Biophys Res Commun 522(2):388\u2013394. https:\/\/doi.org\/10.1016\/j.bbrc.2019.11.102","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1618_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/ijmm.2018.3982","volume":"43","author":"JX Gao","year":"2019","unstructured":"Gao JX, Li Y, Wang SN, Chen XC, Lin LL, Zhang H (2019) Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson\u2019s disease. Int J Mol Med 43(1):209\u2013220. https:\/\/doi.org\/10.3892\/ijmm.2018.3982","journal-title":"Int J Mol Med"},{"key":"1618_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yexmp.2019.05.002","volume":"109","author":"H Ge","year":"2019","unstructured":"Ge H, Yan Z, Zhu H, Zhao H (2019) MiR-410 exerts neuroprotective effects in a cellular model of Parkinson\u2019s disease induced by 6-hydroxydopamine via inhibiting the PTEN\/AKT\/mTOR signaling pathway. Exp Mol Pathol 109:16\u201324. https:\/\/doi.org\/10.1016\/j.yexmp.2019.05.002","journal-title":"Exp Mol Pathol"},{"issue":"18","key":"1618_CR43","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1177\/1535370217734492","volume":"242","author":"L Geng","year":"2017","unstructured":"Geng L, Liu W, Chen Y (2017) Mir-124-3p attenuates MPP(+)-induced neuronal injury by targeting STAT3 in SH-SY5Y cells. Exp Biol Med (Maywood) 242(18):1757\u20131764. https:\/\/doi.org\/10.1177\/1535370217734492","journal-title":"Exp Biol Med (Maywood)"},{"key":"1618_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2018.03.037","volume":"675","author":"L Geng","year":"2018","unstructured":"Geng L, Zhang T, Liu W, Chen Y (2018) Mir-494-3p modulates the progression of in vitro and in vivo Parkinson\u2019s disease models by targeting SIRT3. Neurosci Lett 675:23\u201330. https:\/\/doi.org\/10.1016\/j.neulet.2018.03.037","journal-title":"Neurosci Lett"},{"key":"1618_CR45","unstructured":"Guan Q, Shen H, Yu X, Chu Z, Zhang X (2020) Association of serum neurogenic exosome MicroRNA-211-5p with cognitive impairment in Parkinson's disease and its diagnostic value. Chin J Geriatr 413\u2013417"},{"key":"1618_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051349","author":"BFS Guedes","year":"2023","unstructured":"Guedes BFS, Cardoso SM, Esteves AR (2023) The impact of microRNAs on mitochondrial function and immunity: relevance to Parkinson\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11051349","journal-title":"Biomedicines"},{"issue":"1","key":"1618_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1166\/jbt.2020.2219","volume":"10","author":"Y Guo","year":"2020","unstructured":"Guo Y, Hua X (2020) Microrna-181a-5p down-regulation presents neuroprotective effect in 1-methyl-4-phenylpyridinium-induced Parkinson\u2019s disease: an in vitro study. J Biomater Tissue Eng 10(1):63\u201370","journal-title":"J Biomater Tissue Eng"},{"issue":"1","key":"1618_CR48","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1080\/21655979.2021.1987126","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Liu Y, Wang H, Liu P (2021) Long noncoding RNA SRY-box transcription factor 2 overlapping transcript participates in Parkinson\u2019s disease by regulating the microRNA-942-5p\/nuclear apoptosis-inducing factor 1 axis. Bioengineered 12(1):8570\u20138582. https:\/\/doi.org\/10.1080\/21655979.2021.1987126","journal-title":"Bioengineered"},{"key":"1618_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040307","author":"S Gurunathan","year":"2019","unstructured":"Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH (2019) Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. https:\/\/doi.org\/10.3390\/cells8040307","journal-title":"Cells"},{"issue":"13","key":"1618_CR50","doi-asserted-by":"publisher","first-page":"13518","DOI":"10.18632\/aging.103458","volume":"12","author":"L Han","year":"2020","unstructured":"Han L, Tang Y, Bai X, Liang X, Fan Y, Shen Y, Huang F, Wang J (2020) Association of the serum microRNA-29 family with cognitive impairment in Parkinson\u2019s disease. Aging (Albany NY) 12(13):13518\u201313528. https:\/\/doi.org\/10.18632\/aging.103458","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"1618_CR51","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911942","volume":"12","author":"M Hanan","year":"2020","unstructured":"Hanan M, Simchovitz A, Yayon N, Vaknine S, Cohen-Fultheim R, Karmon M, Madrer N, Rohrlich TM, Maman M, Bennett ER, Greenberg DS, Meshorer E, Levanon EY, Soreq H, Kadener S (2020) A Parkinson\u2019s disease circRNAs resource reveals a link between circSLC8A1 and oxidative stress. EMBO Mol Med 12(9):e11942. https:\/\/doi.org\/10.15252\/emmm.201911942","journal-title":"EMBO Mol Med"},{"issue":"3","key":"1618_CR52","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11011-022-01118-x","volume":"38","author":"Z Hao","year":"2023","unstructured":"Hao Z, Dang W, Zhu Q, Xu J (2023) Long non-coding RNA UCA1 regulates MPP(+)-induced neuronal damage through the miR-671-5p\/KPNA4 pathway in SK-N-SH cells. Metab Brain Dis 38(3):961\u2013972. https:\/\/doi.org\/10.1007\/s11011-022-01118-x","journal-title":"Metab Brain Dis"},{"issue":"6","key":"1618_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13840","volume":"22","author":"L He","year":"2023","unstructured":"He L, Chen Y, Lin S, Shen R, Pan H, Zhou Y, Wang Y, Chen S, Ding J (2023a) Regulation of Hsa-miR-4639-5p expression and its potential role in the pathogenesis of Parkinson\u2019s disease. Aging Cell 22(6):e13840. https:\/\/doi.org\/10.1111\/acel.13840","journal-title":"Aging Cell"},{"issue":"1","key":"1618_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12967-023-04638-x","volume":"21","author":"S He","year":"2023","unstructured":"He S, Wang Q, Chen L, He YJ, Wang X, Qu S (2023b) MiR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson\u2019s disease model via regulation of Nox4\/ROS\/Nrf2 signaling. J Transl Med 21(1):747. https:\/\/doi.org\/10.1186\/s12967-023-04638-x","journal-title":"J Transl Med"},{"issue":"1","key":"1618_CR55","doi-asserted-by":"publisher","DOI":"10.1042\/NS20170181","volume":"2","author":"SV Hegarty","year":"2018","unstructured":"Hegarty SV, Sullivan AM, O\u2019Keeffe GW (2018) Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1\/5-dependent mechanism: implications for Parkinson\u2019s disease. Neuronal Signal 2(1):NS20170181. https:\/\/doi.org\/10.1042\/NS20170181","journal-title":"Neuronal Signal"},{"issue":"52","key":"1618_CR56","doi-asserted-by":"publisher","first-page":"26589","DOI":"10.1074\/jbc.R116.757955","volume":"291","author":"J Howitt","year":"2016","unstructured":"Howitt J, Hill AF (2016) Exosomes in the pathology of neurodegenerative diseases. J Biol Chem 291(52):26589\u201326597. https:\/\/doi.org\/10.1074\/jbc.R116.757955","journal-title":"J Biol Chem"},{"issue":"8","key":"1618_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","volume":"10","author":"YB Hu","year":"2019","unstructured":"Hu YB, Zhang YF, Wang H, Ren RJ, Cui HL, Huang WY, Cheng Q, Chen HZ, Wang G (2019) Mir-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease. Cell Death Dis 10(8):589. https:\/\/doi.org\/10.1038\/s41419-019-1809-5","journal-title":"Cell Death Dis"},{"issue":"8","key":"1618_CR58","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s11011-021-00835-z","volume":"36","author":"H Huang","year":"2021","unstructured":"Huang H, Zheng S, Lu M (2021) Downregulation of lncRNA MEG3 is involved in Parkinson\u2019s disease. Metab Brain Dis 36(8):2323\u20132328. https:\/\/doi.org\/10.1007\/s11011-021-00835-z","journal-title":"Metab Brain Dis"},{"issue":"2","key":"1618_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ana.26421","volume":"92","author":"Y Huang","year":"2022","unstructured":"Huang Y, Liu Z, Li N, Tian C, Yang H, Huo Y, Li Y, Zhang J, Yu Z (2022) Parkinson\u2019s disease derived exosomes aggravate neuropathology in SNCA*A53T mice. Ann Neurol 92(2):230\u2013245. https:\/\/doi.org\/10.1002\/ana.26421","journal-title":"Ann Neurol"},{"key":"1618_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.738442","volume":"15","author":"L Huo","year":"2021","unstructured":"Huo L, Du X, Li X, Liu S, Xu Y (2021) The emerging role of neural cell-derived exosomes in intercellular communication in health and neurodegenerative diseases. Front Neurosci 15:738442. https:\/\/doi.org\/10.3389\/fnins.2021.738442","journal-title":"Front Neurosci"},{"issue":"5","key":"1618_CR61","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/acn3.51480","volume":"9","author":"X Huo","year":"2022","unstructured":"Huo X, Wang L, Shao J, Zhou C, Ying X, Zhao J, Jin X (2022) LINC00667 regulates MPP(+) -induced neuronal injury in Parkinson\u2019s disease. Ann Clin Transl Neurol 9(5):707\u2013721. https:\/\/doi.org\/10.1002\/acn3.51480","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"1618_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21083006","volume":"21","author":"E Jia","year":"2020","unstructured":"Jia E, Zhou Y, Liu Z, Wang L, Ouyang T, Pan M, Bai Y, Ge Q (2020) Transcriptomic profiling of circular RNA in different brain regions of Parkinson\u2019s disease in a mouse model. Int J Mol Sci 21(8):3006. https:\/\/doi.org\/10.3390\/ijms21083006","journal-title":"Int J Mol Sci"},{"key":"1618_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106548","volume":"169","author":"S Jia","year":"2024","unstructured":"Jia S, Yu L, Wang L, Peng L (2024) The functional significance of circRNA\/miRNA\/mRNA interactions as a regulatory network in lung cancer biology. Int J Biochem Cell Biol 169:106548. https:\/\/doi.org\/10.1016\/j.biocel.2024.106548","journal-title":"Int J Biochem Cell Biol"},{"key":"1618_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146331","volume":"1722","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Liu J, Chen L, Jin Y, Zhang G, Lin Z, Du S, Fu Z, Chen T, Qin Y, Sun X (2019) Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson\u2019s disease. Brain Res 1722:146331. https:\/\/doi.org\/10.1016\/j.brainres.2019.146331","journal-title":"Brain Res"},{"issue":"10","key":"1618_CR64","doi-asserted-by":"publisher","first-page":"8820","DOI":"10.18632\/aging.102877","volume":"12","author":"J Jiang","year":"2020","unstructured":"Jiang J, Piao X, Hu S, Gao J, Bao M (2020) LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson\u2019s disease via the HPRT1-mediated Wnt\/beta-catenin signaling pathway. Aging (Albany NY) 12(10):8820\u20138836. https:\/\/doi.org\/10.18632\/aging.102877","journal-title":"Aging (Albany NY)"},{"key":"1618_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121611","author":"Y Jiao","year":"2024","unstructured":"Jiao Y, Yang L, Wang R, Song G, Fu J, Wang J, Gao N, Wang H (2024) Drug delivery across the blood-brain barrier: a new strategy for the treatment of neurological diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16121611","journal-title":"Pharmaceutics"},{"key":"1618_CR67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neulet.2018.09.034","volume":"687","author":"L Jin","year":"2018","unstructured":"Jin L, Wan W, Wang L, Wang C, Xiao J, Zhang F, Zhao J, Wang J, Zhan C, Zhong C (2018) Elevated microRNA-520d-5p in the serum of patients with Parkinson\u2019s disease, possibly through regulation of cereloplasmin expression. Neurosci Lett 687:88\u201393. https:\/\/doi.org\/10.1016\/j.neulet.2018.09.034","journal-title":"Neurosci Lett"},{"key":"1618_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102526","volume":"63","author":"A Kadbhane","year":"2021","unstructured":"Kadbhane A, Patel M, Srivastava S, Singh PK, Madan J, Singh SB, Khatri DK (2021) Perspective insights and application of exosomes as a novel tool against neurodegenerative disorders: an expository appraisal. J Drug Deliv Sci Technol 63:102526. https:\/\/doi.org\/10.1016\/j.jddst.2021.102526","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"1618_CR69","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrg2083","volume":"8","author":"P Kapranov","year":"2007","unstructured":"Kapranov P, Willingham AT, Gingeras TR (2007) Genome-wide transcription and the implications for genomic organization. Nat Rev Genet 8(6):413\u2013423. https:\/\/doi.org\/10.1038\/nrg2083","journal-title":"Nat Rev Genet"},{"issue":"7","key":"1618_CR70","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s10571-021-01093-4","volume":"42","author":"I Khan","year":"2022","unstructured":"Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB (2022) Role of MicroRNAs, aptamers in neuroinflammation and neurodegenerative disorders. Cell Mol Neurobiol 42(7):2075\u20132095. https:\/\/doi.org\/10.1007\/s10571-021-01093-4","journal-title":"Cell Mol Neurobiol"},{"key":"1618_CR71","doi-asserted-by":"publisher","unstructured":"Kumar L, Shamsuzzama, Jadiya P, Haque R, Shukla S, Nazir A (2018) Functional characterization of novel circular RNA molecule, circzip-2 and its synthesizing gene zip-2 in C. elegans model of Parkinson's disease. Mol Neurobiol 55 (8):6914\u20136926. https:\/\/doi.org\/10.1007\/s12035-018-0903-5","DOI":"10.1007\/s12035-018-0903-5"},{"issue":"9","key":"1618_CR72","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.18632\/aging.103028","volume":"12","author":"Y Lang","year":"2020","unstructured":"Lang Y, Li Y, Yu H, Lin L, Chen X, Wang S, Zhang H (2020) HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson\u2019s disease by elevating NPTX2 via miR-221-3p binding. Aging (Albany NY) 12(9):7660\u20137678. https:\/\/doi.org\/10.18632\/aging.103028","journal-title":"Aging (Albany NY)"},{"key":"1618_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna8010010","author":"AL Leitao","year":"2022","unstructured":"Leitao AL, Enguita FJ (2022) A structural view of miRNA biogenesis and function. Noncoding RNA. https:\/\/doi.org\/10.3390\/ncrna8010010","journal-title":"Noncoding RNA"},{"issue":"3\u20134","key":"1618_CR80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12031-017-0994-x","volume":"63","author":"L Li","year":"2017","unstructured":"Li L, Liu H, Song H, Qin Y, Wang Y, Xu M, Liu C, Gao J, Sun S (2017a) Let-7d microrna attenuates 6-OHDA-induced injury by targeting caspase-3 in MN9D cells. J Mol Neurosci 63(3\u20134):403\u2013411. https:\/\/doi.org\/10.1007\/s12031-017-0994-x","journal-title":"J Mol Neurosci"},{"issue":"5","key":"1618_CR83","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","volume":"38","author":"N Li","year":"2017","unstructured":"Li N, Pan X, Zhang J, Ma A, Yang S, Ma J, Xie A (2017b) Plasma levels of miR-137 and miR-124 are associated with Parkinson\u2019s disease but not with Parkinson\u2019s disease with depression. Neurol Sci 38(5):761\u2013767. https:\/\/doi.org\/10.1007\/s10072-017-2841-9","journal-title":"Neurol Sci"},{"issue":"2","key":"1618_CR75","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li D, Yang H, Ma J, Luo S, Chen S, Gu Q (2018a) Microrna-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Hum Cell 31(2):106\u2013115. https:\/\/doi.org\/10.1007\/s13577-017-0187-5","journal-title":"Hum Cell"},{"key":"1618_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2018.03.041","volume":"675","author":"W Li","year":"2018","unstructured":"Li W, Jiang Y, Wang Y, Yang S, Bi X, Pan X, Ma A, Li W (2018b) MiR-181b regulates autophagy in a model of Parkinson\u2019s disease by targeting the PTEN\/Akt\/mTOR signaling pathway. Neurosci Lett 675:83\u201388. https:\/\/doi.org\/10.1016\/j.neulet.2018.03.041","journal-title":"Neurosci Lett"},{"issue":"1","key":"1618_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-019-0140-0","volume":"20","author":"F Li","year":"2019","unstructured":"Li F, Wang Y, Yang H, Xu Y, Zhou X, Zhang X, Xie Z, Bi J (2019) The effect of BACE1-AS on \u03b2-amyloid generation by regulating BACE1 mRNA expression. BMC Mol Biol 20(1):23. https:\/\/doi.org\/10.1186\/s12867-019-0140-0","journal-title":"BMC Mol Biol"},{"key":"1618_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.620020","volume":"14","author":"G Li","year":"2020","unstructured":"Li G, Luo W, Wang B, Qian C, Ye Y, Li Y, Zhang S (2020a) HMGA1 induction of miR-103\/107 forms a negative feedback loop to regulate autophagy in MPTP model of Parkinson\u2019s disease. Front Cell Neurosci 14:620020. https:\/\/doi.org\/10.3389\/fncel.2020.620020","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"1618_CR78","first-page":"6542","volume":"13","author":"J Li","year":"2020","unstructured":"Li J, Shen Q, Ma F, Zhang J, Fang H, Zhang W (2020b) LncRNA MALAT1 affects the biological behavior of Parkinson\u2019s disease model cells by downregulating miR-181a. Int J Clin Exp Med 13(9):6542\u20136550","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"1618_CR85","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Feng Y, Wang XX, Truong D, Wu YC (2020c) The critical role of SIRT1 in Parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis 11(6):1608\u20131622. https:\/\/doi.org\/10.14336\/AD.2020.0216","journal-title":"Aging Dis"},{"issue":"1","key":"1618_CR74","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan JK, He JY, Li S, Liu YS (2021a) Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther 6(1):383. https:\/\/doi.org\/10.1038\/s41392-021-00779-x","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1618_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4894","volume":"47","author":"X Li","year":"2021","unstructured":"Li X, Si W, Li Z, Tian Y, Liu X, Ye S, Huang Z, Ji Y, Zhao C, Hao X, Chen D, Zhu M (2021b) MiR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson\u2019s disease. Int J Mol Med 47(4):1\u201312. https:\/\/doi.org\/10.3892\/ijmm.2021.4894","journal-title":"Int J Mol Med"},{"issue":"4","key":"1618_CR81","doi-asserted-by":"publisher","first-page":"10889","DOI":"10.1080\/21655979.2022.2066750","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Wang H, Li H, Lu X, Gao Y, Guo X (2022a) Long noncoding RNA BACE1-antisense transcript plays a critical role in Parkinson\u2019s disease via microRNA-214-3p\/Cell death-inducing p53-target protein 1 axis. Bioengineered 13(4):10889\u201310901. https:\/\/doi.org\/10.1080\/21655979.2022.2066750","journal-title":"Bioengineered"},{"issue":"10","key":"1618_CR82","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.4103\/1673-5374.335830","volume":"17","author":"MX Li","year":"2022","unstructured":"Li MX, Weng JW, Ho ES, Chow SF, Tsang CK (2022b) Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injury. Neural Regen Res 17(10):2157\u20132165. https:\/\/doi.org\/10.4103\/1673-5374.335830","journal-title":"Neural Regen Res"},{"issue":"2","key":"1618_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/01616412.2022.2129754","volume":"45","author":"J Li","year":"2023","unstructured":"Li J, Sun Z, Song L (2023) LncRNA SNHG15 mediates 1-methyl-4-phenylpyridinium (MPP(+))-induced neuronal damage through targeting miR-29c-3p\/SNCA axis. Neurol Res 45(2):181\u2013190. https:\/\/doi.org\/10.1080\/01616412.2022.2129754","journal-title":"Neurol Res"},{"issue":"7","key":"1618_CR87","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s13258-021-01084-1","volume":"43","author":"H Lian","year":"2021","unstructured":"Lian H, Wang B, Lu Q, Chen B, Yang H (2021) LINC00943 knockdown exerts neuroprotective effects in Parkinson\u2019s disease through regulates CXCL12 expression by sponging miR-7-5p. Genes Genomics 43(7):797\u2013805. https:\/\/doi.org\/10.1007\/s13258-021-01084-1","journal-title":"Genes Genomics"},{"issue":"2","key":"1618_CR88","first-page":"624","volume":"11","author":"H Liang","year":"2018","unstructured":"Liang H, Ding B, Liang J, Shi X, Jiang X, Gao Y (2018) Microrna-10a inhibits A30P alpha-synuclein aggregation and toxicity by targeting proapoptotic protein BCL2L11. Int J Clin Exp Pathol 11(2):624\u2013633","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1618_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113684","volume":"429","author":"Y Liang","year":"2023","unstructured":"Liang Y, Gu M, Liang X, Zhou Y, Yang Q, Wang Z, Yao W, Gao X, Chen S (2023) Von Hippel\u2013Lindau-targeting microRNA-143-3p attenuates mitochondrial abnormality via AMPK\/PGC-1alpha axis in Parkinson\u2019s disease. Exp Cell Res 429(2):113684. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113684","journal-title":"Exp Cell Res"},{"issue":"9","key":"1618_CR90","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1515\/hsz-2018-0431","volume":"400","author":"Q Lin","year":"2019","unstructured":"Lin Q, Hou S, Dai Y, Jiang N, Lin Y (2019) LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson\u2019s disease through RAB3IP. Biol Chem 400(9):1217\u20131228. https:\/\/doi.org\/10.1515\/hsz-2018-0431","journal-title":"Biol Chem"},{"issue":"2","key":"1618_CR92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12017-021-08676-w","volume":"24","author":"X Lin","year":"2022","unstructured":"Lin X, Wang R, Li R, Tao T, Zhang D, Qi Y (2022) Diagnostic performance of miR-485-3p in patients with Parkinson\u2019s disease and its relationship with neuroinflammation. Neuromol Med 24(2):195\u2013201. https:\/\/doi.org\/10.1007\/s12017-021-08676-w","journal-title":"Neuromol Med"},{"issue":"2","key":"1618_CR91","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s13760-023-02388-7","volume":"124","author":"X Lin","year":"2024","unstructured":"Lin X, Tao T, He X, Mao L, Pan L, Chen L (2024) LncRNA MEG8 ameliorates Parkinson\u2019s disease neuro-inflammation through miR-485-3p\/FBXO45 axis. Acta Neurol Belg 124(2):549\u2013557. https:\/\/doi.org\/10.1007\/s13760-023-02388-7","journal-title":"Acta Neurol Belg"},{"issue":"11","key":"1618_CR93","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA (2013) Micrornas and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12(11):847\u2013865. https:\/\/doi.org\/10.1038\/nrd4140","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1618_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-017-0147-5","volume":"7","author":"W Liu","year":"2017","unstructured":"Liu W, Zhang Q, Zhang J, Pan W, Zhao J, Xu Y (2017a) Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease. Cell Biosci 7(1):19. https:\/\/doi.org\/10.1186\/s13578-017-0147-5","journal-title":"Cell Biosci"},{"key":"1618_CR99","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.12659\/msm.900218","volume":"23","author":"Y Liu","year":"2017","unstructured":"Liu Y, Song Y, Zhu X (2017b) Microrna-181a regulates apoptosis and autophagy process in Parkinson\u2019s disease by inhibiting p38 mitogen-activated protein kinase (MAPK)\/c-Jun N-terminal kinases (JNK) signaling pathways. Med Sci Monit 23:1597\u20131606. https:\/\/doi.org\/10.12659\/msm.900218","journal-title":"Med Sci Monit"},{"key":"1618_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7654798","volume":"2019","author":"W Liu","year":"2019","unstructured":"Liu W, Li L, Liu S, Wang Z, Kuang H, Xia Y, Tang C, Yin D (2019) Microrna expression profiling screen miR-3557\/324-targeted CaMK\/mTOR in the rat striatum of Parkinson\u2019s disease in regular aerobic exercise. BioMed Res Int 2019:7654798. https:\/\/doi.org\/10.1155\/2019\/7654798","journal-title":"BioMed Res Int"},{"issue":"2","key":"1618_CR96","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11064-020-03157-1","volume":"46","author":"T Liu","year":"2021","unstructured":"Liu T, Zhang Y, Liu W, Zhao J (2021) LncRNA NEAT1 regulates the development of Parkinson\u2019s disease by targeting AXIN1 via sponging miR-212-3p. Neurochem Res 46(2):230\u2013240. https:\/\/doi.org\/10.1007\/s11064-020-03157-1","journal-title":"Neurochem Res"},{"key":"1618_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.113923","volume":"431","author":"L Liu","year":"2022","unstructured":"Liu L, Zhou T, Li T, Liang Z, Luo X (2022a) LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson\u2019s disease by regulating the miR-223-3p\/NRP1 axis. Behav Brain Res 431:113923. https:\/\/doi.org\/10.1016\/j.bbr.2022.113923","journal-title":"Behav Brain Res"},{"issue":"5","key":"1618_CR95","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-022-04934-2","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, Li Q, Zhang R, Wang H, Li Y, Liu Z, Xie W, Geng D, Wang L (2022b) Circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p\/alpha-syn pathway in Parkinson\u2019s disease. Cell Death Dis 13(5):477. https:\/\/doi.org\/10.1038\/s41419-022-04934-2","journal-title":"Cell Death Dis"},{"issue":"4","key":"1618_CR100","doi-asserted-by":"publisher","first-page":"887","DOI":"10.4103\/1673-5374.322475","volume":"17","author":"P Lun","year":"2022","unstructured":"Lun P, Ji T, Wan DH, Liu X, Chen XD, Yu S, Sun P (2022) HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson\u2019s disease cell and mouse models. Neural Regen Res 17(4):887\u2013897. https:\/\/doi.org\/10.4103\/1673-5374.322475","journal-title":"Neural Regen Res"},{"issue":"20","key":"1618_CR103","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1021\/acschemneuro.0c00375","volume":"11","author":"R Lv","year":"2020","unstructured":"Lv R, Du L, Zhou F, Yuan X, Liu X, Zhang L (2020) Rosmarinic acid alleviates inflammation, apoptosis, and oxidative stress through regulating miR-155-5p in a mice model of Parkinson\u2019s disease. ACS Chem Neurosci 11(20):3259\u20133266. https:\/\/doi.org\/10.1021\/acschemneuro.0c00375","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1618_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-021-00332-8","volume":"54","author":"K Lv","year":"2021","unstructured":"Lv K, Liu Y, Zheng Y, Dai S, Yin P, Miao H (2021a) Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p\/GPNMB axis in Parkinson\u2019s disease cell model. Biol Res 54(1):10. https:\/\/doi.org\/10.1186\/s40659-021-00332-8","journal-title":"Biol Res"},{"issue":"3","key":"1618_CR102","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jnc.15299","volume":"157","author":"Q Lv","year":"2021","unstructured":"Lv Q, Zhong Z, Hu B, Yan S, Yan Y, Zhang J, Shi T, Jiang L, Li W, Huang W (2021b) Microrna-3473b regulates the expression of TREM2\/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease. J Neurochem 157(3):599\u2013610. https:\/\/doi.org\/10.1111\/jnc.15299","journal-title":"J Neurochem"},{"key":"1618_CR105","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresbull.2021.04.026","volume":"174","author":"X Ma","year":"2021","unstructured":"Ma X, Wang Y, Yin H, Hua L, Zhang X, Xiao J, Yuan Q, Wang S, Liu Y, Zhang S, Wang Y (2021a) Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson\u2019s disease rats via regulation of TLR\/NF-kappaB signaling pathway. Brain Res Bull 174:22\u201330. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.04.026","journal-title":"Brain Res Bull"},{"key":"1618_CR106","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainresbull.2020.10.019","volume":"166","author":"X Ma","year":"2021","unstructured":"Ma X, Zhang H, Yin H, Geng S, Liu Y, Liu C, Zhao J, Liu Y, Wang X, Wang Y (2021b) Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson\u2019s disease via suppression of LASP1. Brain Res Bull 166:92\u2013101. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.019","journal-title":"Brain Res Bull"},{"key":"1618_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113904","volume":"347","author":"J Ma","year":"2022","unstructured":"Ma J, Sun W, Chen S, Wang Z, Zheng J, Shi X, Li M, Li D, Gu Q (2022) The long noncoding RNA GAS5 potentiates neuronal injury in Parkinson\u2019s disease by binding to microRNA-150 to regulate Fosl1 expression. Exp Neurol 347:113904. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113904","journal-title":"Exp Neurol"},{"issue":"5","key":"1618_CR107","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-024-06698-3","volume":"15","author":"Y Ma","year":"2024","unstructured":"Ma Y, Wang T, Zhang X, Wang P, Long F (2024) The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications. Cell Death Dis 15(5):312. https:\/\/doi.org\/10.1038\/s41419-024-06698-3","journal-title":"Cell Death Dis"},{"key":"1618_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177529","volume":"998","author":"HM Mansour","year":"2025","unstructured":"Mansour HM, El-Khatib AS (2025) Oligonucleotide-based therapeutics for neurodegenerative disorders: focus on antisense oligonucleotides. Eur J Pharmacol 998:177529. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177529","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1618_CR109","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3892\/etm.2019.7853","volume":"18","author":"H Mao","year":"2019","unstructured":"Mao H, Ding L (2019) Downregulation of miR-21 suppresses 1-methyl-4-phenylpyridinium-induced neuronal damage in MES23.5 cells. Exp Ther Med 18(4):2467\u20132474. https:\/\/doi.org\/10.3892\/etm.2019.7853","journal-title":"Exp Ther Med"},{"issue":"3","key":"1618_CR110","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ncrna.2024.03.014","volume":"9","author":"R Marima","year":"2024","unstructured":"Marima R, Basera A, Miya T, Damane BP, Kandhavelu J, Mirza S, Penny C, Dlamini Z (2024) Exosomal long non-coding RNAs in cancer: interplay, modulation, and therapeutic avenues. Noncoding RNA Res 9(3):887\u2013900. https:\/\/doi.org\/10.1016\/j.ncrna.2024.03.014","journal-title":"Noncoding RNA Res"},{"key":"1618_CR111","doi-asserted-by":"publisher","unstructured":"Markham BN, Ramnarine C, Kim S, Grever WE, Soto-Beasley AI, Heckman M, Ren Y, Osborne AC, Bhagwate AV, Liu Y, Wang C, Kim J, Wszolek ZK, Ross OA, Springer W, Fiesel FC (2024) miRNA family miR-29 inhibits PINK1-PRKN dependent mitophagy via ATG9A. bioRxiv. https:\/\/doi.org\/10.1101\/2024.01.17.576122","DOI":"10.1101\/2024.01.17.576122"},{"issue":"6","key":"1618_CR112","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA, Gingeras TR, Guttman M, Hirose T, Huarte M, Johnson R, Kanduri C, Kapranov P, Lawrence JB, Lee JT, Mendell JT, Mercer TR, Moore KJ, Nakagawa S, Rinn JL, Spector DL, Ulitsky I, Wan Y, Wilusz JE, Wu M (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1618_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/biom12070957","author":"P Mavroeidi","year":"2022","unstructured":"Mavroeidi P, Vetsi M, Dionysopoulou D, Xilouri M (2022) Exosomes in alpha-synucleinopathies: propagators of pathology or potential candidates for nanotherapeutics? Biomolecules. https:\/\/doi.org\/10.3390\/biom12070957","journal-title":"Biomolecules"},{"key":"1618_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1250276","volume":"14","author":"R McCartan","year":"2023","unstructured":"McCartan R, Khorkova O, Volmar CH, Wahlestedt C (2023) Nucleic acid-based therapeutics for the treatment of central nervous system disorders. Front Genet 14:1250276. https:\/\/doi.org\/10.3389\/fgene.2023.1250276","journal-title":"Front Genet"},{"issue":"9","key":"1618_CR115","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/acschemneuro.1c00076","volume":"12","author":"X Meng","year":"2021","unstructured":"Meng X, Zhong J, Zeng C, Yung KKL, Zhang X, Wu X, Qu S (2021) MiR-30a-5p regulates GLT-1 function via a PKCalpha-mediated ubiquitin degradation pathway in a mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 12(9):1578\u20131592. https:\/\/doi.org\/10.1021\/acschemneuro.1c00076","journal-title":"ACS Chem Neurosci"},{"key":"1618_CR116","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA (2012) Parkinson\u2019s disease. Subcell Biochem 65:389\u2013455. https:\/\/doi.org\/10.1007\/978-94-007-5416-4_16","journal-title":"Subcell Biochem"},{"key":"1618_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110002","volume":"362","author":"TK Motawi","year":"2022","unstructured":"Motawi TK, Al-Kady RH, Abdelraouf SM, Senousy MA (2022) Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson\u2019s disease in rats: targeting the GRP78\/PERK\/eIF2alpha\/CHOP pathway and miR-211-5p. Chem Biol Interact 362:110002. https:\/\/doi.org\/10.1016\/j.cbi.2022.110002","journal-title":"Chem Biol Interact"},{"issue":"3","key":"1618_CR118","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211\u2013232. https:\/\/doi.org\/10.1038\/s41576-023-00662-1","journal-title":"Nat Rev Genet"},{"key":"1618_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.661461","volume":"9","author":"SR Oliveira","year":"2021","unstructured":"Oliveira SR, Dionisio PA, Gaspar MM, Correia Guedes L, Coelho M, Rosa MM, Ferreira JJ, Amaral JD, Rodrigues CMP (2021) Mir-335 targets LRRK2 and mitigates inflammation in Parkinson\u2019s disease. Front Cell Dev Biol 9:661461. https:\/\/doi.org\/10.3389\/fcell.2021.661461","journal-title":"Front Cell Dev Biol"},{"key":"1618_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, Wang Z (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9:776847. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","journal-title":"Front Public Health"},{"issue":"4","key":"1618_CR121","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archneur.1969.00480100117017","volume":"20","author":"J Parkinson","year":"1969","unstructured":"Parkinson J (1969) An essay on the shaking palsy. Arch Neurol 20(4):441\u2013445","journal-title":"Arch Neurol"},{"issue":"5","key":"1618_CR122","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4103\/1673-5374.268893","volume":"15","author":"M Pascual","year":"2020","unstructured":"Pascual M, Ibanez F, Guerri C (2020) Exosomes as mediators of neuron-glia communication in neuroinflammation. Neural Regen Res 15(5):796\u2013801. https:\/\/doi.org\/10.4103\/1673-5374.268893","journal-title":"Neural Regen Res"},{"key":"1618_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cells12222660","author":"W Poller","year":"2023","unstructured":"Poller W, Sahoo S, Hajjar R, Landmesser U, Krichevsky AM (2023) Exploration of the noncoding genome for human-specific therapeutic targets\u2014recent insights at molecular and cellular level. Cells. https:\/\/doi.org\/10.3390\/cells12222660","journal-title":"Cells"},{"issue":"1","key":"1618_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111614","volume":"384","author":"C Qian","year":"2019","unstructured":"Qian C, Ye Y, Mao H, Yao L, Sun X, Wang B, Zhang H, Xie L, Zhang H, Zhang Y, Zhang S, He X (2019) Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221\/222\/p27\/mTOR pathway in Parkinson\u2019s disease. Exp Cell Res 384(1):111614. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111614","journal-title":"Exp Cell Res"},{"key":"1618_CR125","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jocn.2019.08.082","volume":"70","author":"LX Qin","year":"2019","unstructured":"Qin LX, Tan JQ, Zhang HN, Tang JG, Jiang B, Shen XM, Tang BS, Wang CY (2019) Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson\u2019s disease patients. J Clin Neurosci 70:198\u2013201. https:\/\/doi.org\/10.1016\/j.jocn.2019.08.082","journal-title":"J Clin Neurosci"},{"issue":"8","key":"1618_CR126","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/1061186X.2021.1886300","volume":"29","author":"X Qin","year":"2021","unstructured":"Qin X, Zhang X, Li P, Wang M, Yan L, Pan P, Zhang H, Hong X, Liu M, Bao Z (2021) Microrna-185 activates PI3K\/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson\u2019s disease. J Drug Target 29(8):875\u2013883. https:\/\/doi.org\/10.1080\/1061186X.2021.1886300","journal-title":"J Drug Target"},{"key":"1618_CR127","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5019815","volume":"2019","author":"A Rahimmi","year":"2019","unstructured":"Rahimmi A, Peluso I, Rajabi A, Hassanzadeh K (2019) MiR-185 and SEPT5 genes may contribute to Parkinson\u2019s disease pathophysiology. Oxid Med Cell Longev 2019:5019815. https:\/\/doi.org\/10.1155\/2019\/5019815","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"1618_CR128","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC (2020) Micrornas (miRNAs) and long non-coding RNAs (lncrnas) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol 15(3):261\u2013278. https:\/\/doi.org\/10.1007\/s11523-020-00717-x","journal-title":"Target Oncol"},{"issue":"6","key":"1618_CR129","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3892\/mmr.2019.10176","volume":"19","author":"Y Ren","year":"2019","unstructured":"Ren Y, Li H, Xie W, Wei N, Liu M (2019) Microrna-195 triggers neuroinflammation in Parkinson\u2019s disease in a Rho-associated kinase 1-dependent manner. Mol Med Rep 19(6):5153\u20135161. https:\/\/doi.org\/10.3892\/mmr.2019.10176","journal-title":"Mol Med Rep"},{"key":"1618_CR130","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.gene.2018.04.010","volume":"662","author":"M Rostamian Delavar","year":"2018","unstructured":"Rostamian Delavar M, Baghi M, Safaeinejad Z, Kiani-Esfahani A, Ghaedi K, Nasr-Esfahani MH (2018) Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson\u2019s disease. Gene 662:54\u201365. https:\/\/doi.org\/10.1016\/j.gene.2018.04.010","journal-title":"Gene"},{"key":"1618_CR131","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1715985","volume":"2016","author":"DM Rotroff","year":"2016","unstructured":"Rotroff DM, Motsinger-Reif AA (2016) Embracing integrative multiomics approaches. Int J Genomics 2016:1715985. https:\/\/doi.org\/10.1155\/2016\/1715985","journal-title":"Int J Genomics"},{"issue":"8","key":"1618_CR132","doi-asserted-by":"publisher","first-page":"962","DOI":"10.22038\/ijbms.2025.85350.18446","volume":"28","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Qahtan SA, Albadr RJ, Sanghvi G, Roopashree R, Kashyap A, Sabarivani A, Rizaev J, Taher WM, Alwan M, Jawad MJ, Al-Nuaimi AMA (2025) Non-coding RNAs as key players in neurodegeneration and brain tumors: insights into therapeutic strategies. Iran J Basic Med Sci 28(8):962\u2013985. https:\/\/doi.org\/10.22038\/ijbms.2025.85350.18446","journal-title":"Iran J Basic Med Sci"},{"key":"1618_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125186","volume":"670","author":"Z Sadat Razavi","year":"2025","unstructured":"Sadat Razavi Z, Sina Alizadeh S, Sadat Razavi F, Souri M, Soltani M (2025) Advancing neurological disorders therapies: organic nanoparticles as a key to blood\u2013brain barrier penetration. Int J Pharm 670:125186. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125186","journal-title":"Int J Pharm"},{"issue":"23","key":"1618_CR134","doi-asserted-by":"publisher","first-page":"16600","DOI":"10.3390\/ijms242316600","volume":"24","author":"I Salido-Guadarrama","year":"2023","unstructured":"Salido-Guadarrama I, Romero-Cordoba SL, Rueda-Zarazua B (2023) Multi-omics mining of lncRNAs with biological and clinical relevance in cancer. Int J Mol Sci 24(23):16600","journal-title":"Int J Mol Sci"},{"key":"1618_CR135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2018.06.061","volume":"674","author":"N Salimian","year":"2018","unstructured":"Salimian N, Peymani M, Ghaedi K, Nasr Esfahani MH (2018) Modulation in miR-200a\/SIRT1axis is associated with apoptosis in MPP(+)-induced SH-SY5Y cells. Gene 674:25\u201330. https:\/\/doi.org\/10.1016\/j.gene.2018.06.061","journal-title":"Gene"},{"issue":"5","key":"1618_CR136","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00018-017-2656-0","volume":"75","author":"H Seok","year":"2018","unstructured":"Seok H, Lee H, Jang ES, Chi SW (2018) Evaluation and control of miRNA-like off-target repression for RNA interference. Cell Mol Life Sci 75(5):797\u2013814. https:\/\/doi.org\/10.1007\/s00018-017-2656-0","journal-title":"Cell Mol Life Sci"},{"key":"1618_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031469","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA (2024) Trials and tribulations of MicroRNA therapeutics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031469","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1618_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"N Shaheen","year":"2024","unstructured":"Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O (2024) Micrornas regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis 10(1):186. https:\/\/doi.org\/10.1038\/s41531-024-00791-2","journal-title":"NPJ Parkinsons Dis"},{"key":"1618_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.premed.2025.100016","volume":"3","author":"U Shahid","year":"2025","unstructured":"Shahid U (2025) Advances in RNA therapeutics: classes, innovations and clinical applications. J Precis Med Health Dis 3:100016. https:\/\/doi.org\/10.1016\/j.premed.2025.100016","journal-title":"J Precis Med Health Dis"},{"issue":"5","key":"1618_CR140","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s11064-020-02977-5","volume":"45","author":"N Shakespear","year":"2020","unstructured":"Shakespear N, Ogura M, Yamaki J, Homma Y (2020) Astrocyte-derived exosomal microRNA miR-200a-3p prevents MPP(+)-induced apoptotic cell death through down-regulation of MKK4. Neurochem Res 45(5):1020\u20131033. https:\/\/doi.org\/10.1007\/s11064-020-02977-5","journal-title":"Neurochem Res"},{"issue":"6","key":"1618_CR141","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/mgg3.469","volume":"6","author":"Z Shanesazzade","year":"2018","unstructured":"Shanesazzade Z, Peymani M, Ghaedi K, Nasr Esfahani MH (2018) Mir-34a\/BCL-2 signaling axis contributes to apoptosis in MPP(+)-induced SH-SY5Y cells. Mol Genet Genomic Med 6(6):975\u2013981. https:\/\/doi.org\/10.1002\/mgg3.469","journal-title":"Mol Genet Genomic Med"},{"issue":"9","key":"1618_CR142","first-page":"9993","volume":"13","author":"Y Shen","year":"2021","unstructured":"Shen Y, Cui X, Hu Y, Zhang Z, Zhang Z (2021) Lncrna-MIAT regulates the growth of SHSY5Y cells by regulating the miR-34-5p-SYT1 axis and exerts a neuroprotective effect in a mouse model of Parkinson\u2019s disease. Am J Transl Res 13(9):9993\u201310013","journal-title":"Am J Transl Res"},{"issue":"4","key":"1618_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102373","volume":"35","author":"P Shirmast","year":"2024","unstructured":"Shirmast P, Shahri MA, Brent A, Idris A, McMillan NAJ (2024) Delivering therapeutic RNA into the brain using extracellular vesicles. Mol Ther Nucleic Acids 35(4):102373. https:\/\/doi.org\/10.1016\/j.omtn.2024.102373","journal-title":"Mol Ther Nucleic Acids"},{"issue":"10","key":"1618_CR144","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1096\/fj.201900830R","volume":"33","author":"A Simchovitz","year":"2019","unstructured":"Simchovitz A, Hanan M, Niederhoffer N, Madrer N, Yayon N, Bennett ER, Greenberg DS, Kadener S, Soreq H (2019) NEAT1 is overexpressed in Parkinson\u2019s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress. FASEB J 33(10):11223\u201311234. https:\/\/doi.org\/10.1096\/fj.201900830R","journal-title":"FASEB J"},{"issue":"1","key":"1618_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312. https:\/\/doi.org\/10.1016\/j.cger.2019.08.002","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"1618_CR146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13721-024-00445-6","volume":"13","author":"G Singh","year":"2024","unstructured":"Singh G, Khatri DK (2024) Microrna-gene regulatory network of TLR signaling in neuroinflammation-induced Parkinson\u2019s disease: a bioinformatics approach. Netw Model Anal Health Inform Bioinform 13(1):7. https:\/\/doi.org\/10.1007\/s13721-024-00445-6","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"1618_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130728","volume":"264","author":"G Singh","year":"2024","unstructured":"Singh G, Mehra A, Arora S, Gugulothu D, Vora LK, Prasad R, Khatri DK (2024) Exosome-mediated delivery and regulation in neurological disease progression. Int J Biol Macromol 264:130728. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130728","journal-title":"Int J Biol Macromol"},{"key":"1618_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00061","volume":"7","author":"J Song","year":"2015","unstructured":"Song J, Lee JE (2015) miR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function. Front Aging Neurosci 7:61. https:\/\/doi.org\/10.3389\/fnagi.2015.00061","journal-title":"Front Aging Neurosci"},{"key":"1618_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135482","volume":"740","author":"Z Song","year":"2021","unstructured":"Song Z, Xie B (2021) LncRNA OIP5-AS1 reduces alpha-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells. Neurosci Lett 740:135482. https:\/\/doi.org\/10.1016\/j.neulet.2020.135482","journal-title":"Neurosci Lett"},{"issue":"3","key":"1618_CR150","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3349\/ymj.2018.59.3.416","volume":"59","author":"Y Song","year":"2018","unstructured":"Song Y, Liu Y, Chen X (2018) Mir-212 attenuates MPP(+)-induced neuronal damage by targeting KLF4 in SH-SY5Y cells. Yonsei Med J 59(3):416\u2013424. https:\/\/doi.org\/10.3349\/ymj.2018.59.3.416","journal-title":"Yonsei Med J"},{"key":"1618_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2019.101668","volume":"101","author":"Q Song","year":"2019","unstructured":"Song Q, Geng Y, Li Y, Wang L, Qin J (2019) Long noncoding RNA NORAD regulates MPP+-induced Parkinson\u2019s disease model cells. J Chem Neuroanat 101:101668. https:\/\/doi.org\/10.1016\/j.jchemneu.2019.101668","journal-title":"J Chem Neuroanat"},{"key":"1618_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2022.02.007","volume":"28","author":"CS Stein","year":"2022","unstructured":"Stein CS, McLendon JM, Witmer NH, Boudreau RL (2022) Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson\u2019s disease. Mol Ther Nucleic Acids 28:1\u201315. https:\/\/doi.org\/10.1016\/j.omtn.2022.02.007","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"1618_CR153","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, Hu B, Chen JG, Zhu X, Man HY, Lu Y, Liu D, Tang B, Zhu LQ (2019) Microrna-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease. Biol Psychiatry 85(9):769\u2013781. https:\/\/doi.org\/10.1016\/j.biopsych.2018.12.008","journal-title":"Biol Psychiatry"},{"key":"1618_CR156","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnmol.2018.00381","volume":"11","author":"S Sun","year":"2018","unstructured":"Sun S, Han X, Li X, Song Q, Lu M, Jia M, Ding J, Hu G (2018a) Microrna-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson\u2019s disease. Front Mol Neurosci 11:381. https:\/\/doi.org\/10.3389\/fnmol.2018.00381","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1618_CR158","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12943-018-0831-z","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Xu J, Xia K, Chang Y, Liu J, Yuan W (2018b) Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Mol Cancer 17(1):82. https:\/\/doi.org\/10.1186\/s12943-018-0831-z","journal-title":"Mol Cancer"},{"issue":"2","key":"1618_CR154","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12031-020-01660-2","volume":"71","author":"Q Sun","year":"2021","unstructured":"Sun Q, Zhang Y, Wang S, Yang F, Cai H, Xing Y, Chen Z, Chen J (2021) NEAT1 decreasing suppresses Parkinson\u2019s disease progression via acting as miR-1301-3p sponge. J Mol Neurosci 71(2):369\u2013378. https:\/\/doi.org\/10.1007\/s12031-020-01660-2","journal-title":"J Mol Neurosci"},{"issue":"1","key":"1618_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113132","volume":"417","author":"Q Sun","year":"2022","unstructured":"Sun Q, Zhang Y, Wang S, Yang F, Cai H, Xing Y, Zhou L, Chen S, Wang Y (2022a) LncRNA HOTAIR promotes alpha-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson\u2019s disease. Exp Cell Res 417(1):113132. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113132","journal-title":"Exp Cell Res"},{"key":"1618_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.147814","volume":"1782","author":"X Sun","year":"2022","unstructured":"Sun X, Zhang C, Tao H, Yao S, Wu X (2022b) LINC00943 acts as miR-338-3p sponge to promote MPP(+)-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson\u2019s disease. Brain Res 1782:147814. https:\/\/doi.org\/10.1016\/j.brainres.2022.147814","journal-title":"Brain Res"},{"issue":"3","key":"1618_CR159","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.548","volume":"7","author":"M Talepoor Ardakani","year":"2019","unstructured":"Talepoor Ardakani M, Rostamian Delavar M, Baghi M, Nasr-Esfahani MH, Kiani-Esfahani A, Ghaedi K (2019) Upregulation of miR-200a and miR-204 in MPP(+)-treated differentiated PC12 cells as a model of Parkinson\u2019s disease. Mol Genet Genomic Med 7(3):e548. https:\/\/doi.org\/10.1002\/mgg3.548","journal-title":"Mol Genet Genomic Med"},{"key":"1618_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.755254","volume":"9","author":"X Tan","year":"2021","unstructured":"Tan X, Hu J, Ming F, Lv L, Yan W, Peng X, Bai R, Xiao Q, Zhang H, Tang B, Wang C, Tan J (2021) Microrna-409-3p targeting at ATXN3 reduces the apoptosis of dopamine neurons based on the profile of miRNAs in the cerebrospinal fluid of early Parkinson\u2019s disease. Front Cell Dev Biol 9:755254. https:\/\/doi.org\/10.3389\/fcell.2021.755254","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"1618_CR161","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3892\/ijmm.2019.4426","volume":"45","author":"H Tao","year":"2020","unstructured":"Tao H, Liu Y, Hou Y (2020) MiRNA-384-5p regulates the progression of Parkinson\u2019s disease by targeting SIRT1 in mice and SH-SY5Y cell. Int J Mol Med 45(2):441\u2013450. https:\/\/doi.org\/10.3892\/ijmm.2019.4426","journal-title":"Int J Mol Med"},{"key":"1618_CR162","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tiv.2017.10.003","volume":"46","author":"P Tarale","year":"2018","unstructured":"Tarale P, Daiwile AP, Sivanesan S, Stoger R, Bafana A, Naoghare PK, Parmar D, Chakrabarti T, Krishnamurthi K (2018) Manganese exposure: linking down-regulation of miRNA-7 and miRNA-433 with alpha-synuclein overexpression and risk of idiopathic Parkinson\u2019s disease. Toxicol in Vitro 46:94\u2013101. https:\/\/doi.org\/10.1016\/j.tiv.2017.10.003","journal-title":"Toxicol in Vitro"},{"key":"1618_CR163","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnmol.2019.00254","volume":"12","author":"K Tielking","year":"2019","unstructured":"Tielking K, Fischer S, Preissner KT, Vajkoczy P, Xu R (2019) Extracellular RNA in central nervous system pathologies. Front Mol Neurosci 12:254. https:\/\/doi.org\/10.3389\/fnmol.2019.00254","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"1618_CR164","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1566523218666180430121323","volume":"18","author":"R Titze-de-Almeida","year":"2018","unstructured":"Titze-de-Almeida R, Titze-de-Almeida SS (2018) MiR-7 replacement therapy in Parkinson\u2019s disease. Curr Gene Ther 18(3):143\u2013153. https:\/\/doi.org\/10.2174\/1566523218666180430121323","journal-title":"Curr Gene Ther"},{"issue":"s1","key":"1618_CR165","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.3233\/jad-220449","volume":"94","author":"KP Tryphena","year":"2023","unstructured":"Tryphena KP, Anuradha U, Kumar R, Rajan S, Srivastava S, Singh SB, Khatri DK (2023a) Understanding the involvement of microRNAs in mitochondrial dysfunction and their role as potential biomarkers and therapeutic targets in Parkinson\u2019s disease. J Alzheimers Dis 94(s1):S187\u2013S202. https:\/\/doi.org\/10.3233\/jad-220449","journal-title":"J Alzheimers Dis"},{"key":"1618_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111800","volume":"211","author":"KP Tryphena","year":"2023","unstructured":"Tryphena KP, Singh G, Jain N, Famta P, Srivastava S, Singh SB, Khatri DK (2023b) Integration of miRNA\u2019s theranostic potential with nanotechnology: promises and challenges for Parkinson\u2019s disease therapeutics. Mech Ageing Dev 211:111800. https:\/\/doi.org\/10.1016\/j.mad.2023.111800","journal-title":"Mech Ageing Dev"},{"issue":"12","key":"1618_CR168","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1093\/brain\/awad265","volume":"146","author":"N Vijiaratnam","year":"2023","unstructured":"Vijiaratnam N, Foltynie T (2023) How should we be using biomarkers in trials of disease modification in Parkinson\u2019s disease? Brain 146(12):4845\u20134869. https:\/\/doi.org\/10.1093\/brain\/awad265","journal-title":"Brain"},{"issue":"15","key":"1618_CR179","doi-asserted-by":"publisher","first-page":"24449","DOI":"10.18632\/oncotarget.15511","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Zhang X, Guo Y, Rong H, Liu T (2017) The long noncoding RNA HOTAIR promotes Parkinson\u2019s disease by upregulating LRRK2 expression. Oncotarget 8(15):24449\u201324456. https:\/\/doi.org\/10.18632\/oncotarget.15511","journal-title":"Oncotarget"},{"issue":"10","key":"1618_CR174","first-page":"6619","volume":"11","author":"M Wang","year":"2019","unstructured":"Wang M, Sun H, Yao Y, Tang X, Wu B (2019a) Microrna-217\/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP(+)-induced SH-SY5Y cells. Am J Transl Res 11(10):6619\u20136631","journal-title":"Am J Transl Res"},{"key":"1618_CR183","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2019.02.038","volume":"701","author":"Z Wang","year":"2019","unstructured":"Wang Z, Sun L, Jia K, Wang H, Wang X (2019b) miR-9-5p modulates the progression of Parkinson\u2019s disease by targeting SIRT1. Neurosci Lett 701:226\u2013233. https:\/\/doi.org\/10.1016\/j.neulet.2019.02.038","journal-title":"Neurosci Lett"},{"key":"1618_CR175","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.omtn.2020.06.008","volume":"21","author":"M Wang","year":"2020","unstructured":"Wang M, Yu F, Li P, Wang K (2020a) Emerging function and clinical significance of exosomal circRNAs in cancer. Mol Ther Nucleic Acids 21:367\u2013383. https:\/\/doi.org\/10.1016\/j.omtn.2020.06.008","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"1618_CR176","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/cns.13277","volume":"26","author":"Q Wang","year":"2020","unstructured":"Wang Q, Han CL, Wang KL, Sui YP, Li ZB, Chen N, Fan SY, Shimabukuro M, Wang F, Meng FG (2020b) Integrated analysis of exosomal lncRNA and mRNA expression profiles reveals the involvement of lnc-MKRN2-42:1 in the pathogenesis of Parkinson\u2019s disease. CNS Neurosci Ther 26(5):527\u2013537. https:\/\/doi.org\/10.1111\/cns.13277","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"1618_CR169","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s12640-021-00437-8","volume":"39","author":"C Wang","year":"2021","unstructured":"Wang C, Zhang H, Li J (2021a) LncRNA JHDM1D-AS1 suppresses MPP+-induced neuronal injury in Parkinson\u2019s disease via miR-134-5p\/PIK3R3 axis. Neurotox Res 39(6):1771\u20131781. https:\/\/doi.org\/10.1007\/s12640-021-00437-8","journal-title":"Neurotox Res"},{"key":"1618_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.104972","volume":"146","author":"DX Wang","year":"2021","unstructured":"Wang DX, Yang Y, Huang XS, Tang JY, Zhang X, Huang HX, Zhou B, Liu B, Xiao HQ, Li XH, Yang P, Zou SC, Liu K, Wang XY, Li XS (2021b) Pramipexole attenuates neuronal injury in Parkinson\u2019s disease by targeting miR-96 to activate BNIP3-mediated mitophagy. Neurochem Int 146:104972. https:\/\/doi.org\/10.1016\/j.neuint.2021.104972","journal-title":"Neurochem Int"},{"issue":"2","key":"1618_CR172","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10735-020-09931-3","volume":"52","author":"H Wang","year":"2021","unstructured":"Wang H, Wang X, Zhang Y, Zhao J (2021c) LncRNA SNHG1 promotes neuronal injury in Parkinson\u2019s disease cell model by miR-181a-5p\/CXCL12 axis. J Mol Histol 52(2):153\u2013163. https:\/\/doi.org\/10.1007\/s10735-020-09931-3","journal-title":"J Mol Histol"},{"issue":"10","key":"1618_CR173","doi-asserted-by":"publisher","first-page":"851","DOI":"10.21037\/atm-21-1613","volume":"9","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang M, Wei T, Zhou J, Zhang Y, Guo D (2021d) Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson\u2019s disease model cells by regulating miR-216a-3p\/Bcl-2-associated X protein. Ann Transl Med 9(10):851. https:\/\/doi.org\/10.21037\/atm-21-1613","journal-title":"Ann Transl Med"},{"key":"1618_CR178","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.wneu.2021.08.147","volume":"156","author":"S Wang","year":"2021","unstructured":"Wang S, Wen Q, Xiong B, Zhang L, Yu X, Ouyang X (2021f) Long noncoding RNA NEAT1 knockdown ameliorates 1-methyl-4-phenylpyridine-induced cell injury through microRNA-519a-3p\/SP1 axis in Parkinson disease. World Neurosurg 156:e93\u2013e103. https:\/\/doi.org\/10.1016\/j.wneu.2021.08.147","journal-title":"World Neurosurg"},{"issue":"1","key":"1618_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12179","volume":"24","author":"W Wang","year":"2021","unstructured":"Wang W, Lv R, Zhang J, Liu Y (2021g) CircSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK\/mTOR pathway in Parkinson\u2019s disease. Mol Med Rep 24(1):1\u201310. https:\/\/doi.org\/10.3892\/mmr.2021.12179","journal-title":"Mol Med Rep"},{"issue":"7","key":"1618_CR181","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s11064-021-03333-x","volume":"46","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Z, Wang F (2021h) Microrna-93 blocks signal transducers and activator of transcription 3 to reduce neuronal damage in Parkinson\u2019s disease. Neurochem Res 46(7):1859\u20131868. https:\/\/doi.org\/10.1007\/s11064-021-03333-x","journal-title":"Neurochem Res"},{"issue":"1","key":"1618_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04881-w","volume":"22","author":"D Wang","year":"2024","unstructured":"Wang D, Gao H, Qin Q, Li J, Zhao J, Qu Y, Li J, Xiong Y, Min Z, Mao Z, Xue Z (2024) Microrna-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson\u2019s disease. J Transl Med 22(1):63. https:\/\/doi.org\/10.1186\/s12967-024-04881-w","journal-title":"J Transl Med"},{"issue":"68","key":"1618_CR184","first-page":"124","volume":"15","author":"H Wei","year":"2021","unstructured":"Wei H, Hu Y, Yang LJTPH (2021) Intestinal flora imbalance affects the prognosis of Parkinson\u2019s disease by regulating the expression of fecal microRNA-146a and GDNF: a preliminary study. Termedia Publ House 15(68):124\u2013128","journal-title":"Termedia Publ House"},{"issue":"1","key":"1618_CR185","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3892\/mmr.2017.7897","volume":"17","author":"Z Wen","year":"2018","unstructured":"Wen Z, Zhang J, Tang P, Tu N, Wang K, Wu G (2018) Overexpression of miR-185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK\/mTOR signaling pathway in Parkinson\u2019s disease. Mol Med Rep 17(1):131\u2013137. https:\/\/doi.org\/10.3892\/mmr.2017.7897","journal-title":"Mol Med Rep"},{"issue":"1","key":"1618_CR186","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41531-024-00636-y","volume":"10","author":"BJ Whittle","year":"2024","unstructured":"Whittle BJ, Izuogu OG, Lowes H, Deen D, Pyle A, Coxhead J, Lawson RA, Yarnall AJ, Jackson MS, Santibanez-Koref M, Hudson G (2024) Early-stage idiopathic Parkinson\u2019s disease is associated with reduced circular RNA expression. NPJ Parkinsons Dis 10(1):25. https:\/\/doi.org\/10.1038\/s41531-024-00636-y","journal-title":"NPJ Parkinsons Dis"},{"issue":"8","key":"1618_CR187","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Noncoding RNA therapeutics\u2014challenges and potential solutions. Nat Rev Drug Discov 20(8):629\u2013651. https:\/\/doi.org\/10.1038\/s41573-021-00219-z","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1618_CR189","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1021\/acschemneuro.8b00683","volume":"10","author":"X Wu","year":"2019","unstructured":"Wu X, Meng X, Tan F, Jiao Z, Zhang X, Tong H, He X, Luo X, Xu P, Qu S (2019) Regulatory mechanism of miR-543-3p on GLT-1 in a mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 10(3):1791\u20131800. https:\/\/doi.org\/10.1021\/acschemneuro.8b00683","journal-title":"ACS Chem Neurosci"},{"key":"1618_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.865139","volume":"16","author":"L Wu","year":"2022","unstructured":"Wu L, Xu Q, Zhou M, Chen Y, Jiang C, Jiang Y, Lin Y, He Q, Zhao L, Dong Y, Liu J, Chen W (2022a) Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson\u2019s disease. Front Neurosci 16:865139. https:\/\/doi.org\/10.3389\/fnins.2022.865139","journal-title":"Front Neurosci"},{"issue":"7","key":"1618_CR190","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.ymthe.2022.03.011","volume":"30","author":"Y Wu","year":"2022","unstructured":"Wu Y, Li P, Liu L, Goodwin AJ, Halushka PV, Hirose T, Nakagawa S, Zhou J, Liu M, Fan H (2022b) LncRNA Neat1 regulates neuronal dysfunction post-sepsis via stabilization of hemoglobin subunit beta. Mol Ther 30(7):2618\u20132632. https:\/\/doi.org\/10.1016\/j.ymthe.2022.03.011","journal-title":"Mol Ther"},{"issue":"4","key":"1618_CR191","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1002\/jcb.27769","volume":"120","author":"D Xia","year":"2019","unstructured":"Xia D, Sui R, Zhang Z (2019a) Administration of resveratrol improved Parkinson\u2019s disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1\/miR-129\/SNCA signaling pathway. J Cell Biochem 120(4):4942\u20134951. https:\/\/doi.org\/10.1002\/jcb.27769","journal-title":"J Cell Biochem"},{"issue":"3","key":"1618_CR192","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","volume":"10","author":"Y Xia","year":"2019","unstructured":"Xia Y, Zhang G, Han C, Ma K, Guo X, Wan F, Kou L, Yin S, Liu L, Huang J, Xiong N, Wang T (2019b) Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 10(3):174. https:\/\/doi.org\/10.1038\/s41419-019-1404-9","journal-title":"Cell Death Dis"},{"key":"1618_CR193","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/NDT.S286778","volume":"17","author":"X Xiao","year":"2021","unstructured":"Xiao X, Tan Z, Jia M, Zhou X, Wu K, Ding Y, Li W (2021) Long noncoding RNA SNHG1 knockdown ameliorates apoptosis, oxidative stress and inflammation in models of Parkinson\u2019s disease by inhibiting the miR-125b-5p\/MAPK1 axis. Neuropsychiatr Dis Treat 17:1153\u20131163. https:\/\/doi.org\/10.2147\/NDT.S286778","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1618_CR194","doi-asserted-by":"publisher","first-page":"9173514","DOI":"10.1155\/2022\/9173514","volume":"2022","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Yan Z, Sun X, Zhu Z, Wang B, Gao M, Lu F, Liu J, Zong Z, Zhang H, Guo Y (2022) MiR-9-5p inhibits the MMP(+)-induced neuron apoptosis through regulating SCRIB\/beta-catenin signaling in Parkinson\u2019s disease. Oxid Med Cell Longev 2022:9173514. https:\/\/doi.org\/10.1155\/2022\/9173514","journal-title":"Oxid Med Cell Longev"},{"key":"1618_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134340","volume":"708","author":"SP Xie","year":"2019","unstructured":"Xie SP, Zhou F, Li J, Duan SJ (2019) NEAT1 regulates MPP(+)-induced neuronal injury by targeting miR-124 in neuroblastoma cells. Neurosci Lett 708:134340. https:\/\/doi.org\/10.1016\/j.neulet.2019.134340","journal-title":"Neurosci Lett"},{"issue":"10","key":"1618_CR196","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/kjm2.12241","volume":"36","author":"RX Xing","year":"2020","unstructured":"Xing RX, Li LG, Liu XW, Tian BX, Cheng Y (2020) Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson\u2019s disease via activating NF-kappaB signaling. Kaohsiung J Med Sci 36(10):786\u2013792. https:\/\/doi.org\/10.1002\/kjm2.12241","journal-title":"Kaohsiung J Med Sci"},{"key":"1618_CR197","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8181374","volume":"2018","author":"X Xu","year":"2018","unstructured":"Xu X, Zhuang C, Wu Z, Qiu H, Feng H, Wu J (2018) LincRNA-p21 inhibits cell viability and promotes cell apoptosis in Parkinson\u2019s disease through activating \u03b1-synuclein expression. BioMed Res Int 2018:8181374. https:\/\/doi.org\/10.1155\/2018\/8181374","journal-title":"BioMed Res Int"},{"issue":"4","key":"1618_CR199","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.bbrc.2017.12.149","volume":"496","author":"W Yan","year":"2018","unstructured":"Yan W, Chen ZY, Chen JQ, Chen HM (2018) LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson\u2019s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun 496(4):1019\u20131024. https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.149","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1618_CR198","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1080\/21655979.2021.2005928","volume":"12","author":"L Yan","year":"2021","unstructured":"Yan L, Li L, Lei J (2021) Long noncoding RNA small nucleolar RNA host gene 12\/microRNA-138-5p\/nuclear factor I\/B regulates neuronal apoptosis, inflammatory response, and oxidative stress in Parkinson\u2019s disease. Bioengineered 12(2):12867\u201312879. https:\/\/doi.org\/10.1080\/21655979.2021.2005928","journal-title":"Bioengineered"},{"issue":"5","key":"1618_CR204","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1021\/acschemneuro.8b00460","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li T, Li S, Wei M, Qi H, Shen B, Chang RC, Le W, Piao F (2019) Altered expression levels of microRNA-132 and Nurr1 in peripheral blood of Parkinson\u2019s disease: potential disease biomarkers. ACS Chem Neurosci 10(5):2243\u20132249. https:\/\/doi.org\/10.1021\/acschemneuro.8b00460","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"1618_CR202","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11011-020-00546-x","volume":"35","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang M, Wei M, Wang A, Deng Y, Cao H (2020) MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax. Metab Brain Dis 35(4):627\u2013635. https:\/\/doi.org\/10.1007\/s11011-020-00546-x","journal-title":"Metab Brain Dis"},{"key":"1618_CR200","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.omtn.2022.01.009","volume":"27","author":"K Yang","year":"2022","unstructured":"Yang K, Zhou Q, Qiao B, Shao B, Hu S, Wang G, Yuan W, Sun Z (2022a) Exosome-derived noncoding RNAs: function, mechanism, and application in tumor angiogenesis. Mol Ther Nucleic Acids 27:983\u2013997. https:\/\/doi.org\/10.1016\/j.omtn.2022.01.009","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1618_CR201","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24037","volume":"36","author":"P Yang","year":"2022","unstructured":"Yang P, Lin G, Wang M, Chen X, Huang J (2022b) Long non-coding RNA ANRIL interacts with microRNA-34a and microRNA-125a, and they all correlate with disease risk and severity of Parkinson\u2019s disease. J Clin Lab Anal 36(1):e24037. https:\/\/doi.org\/10.1002\/jcla.24037","journal-title":"J Clin Lab Anal"},{"key":"1618_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175302","volume":"934","author":"YL Yang","year":"2022","unstructured":"Yang YL, Lin TK, Huang YH (2022c) MiR-29a inhibits MPP+-induced cell death and inflammation in Parkinson\u2019s disease model in vitro by potential targeting of MAVS. Eur J Pharmacol 934:175302. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175302","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1618_CR205","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1053-4","volume":"15","author":"L Yao","year":"2018","unstructured":"Yao L, Ye Y, Mao H, Lu F, He X, Lu G, Zhang S (2018) Microrna-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. J Neuroinflamm 15(1):13. https:\/\/doi.org\/10.1186\/s12974-018-1053-4","journal-title":"J Neuroinflamm"},{"issue":"7","key":"1618_CR206","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","volume":"33","author":"L Yao","year":"2019","unstructured":"Yao L, Zhu Z, Wu J, Zhang Y, Zhang H, Sun X, Qian C, Wang B, Xie L, Zhang S, Lu G (2019) Microrna-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. FASEB J 33(7):8648\u20138665. https:\/\/doi.org\/10.1096\/fj.201900363R","journal-title":"FASEB J"},{"issue":"11","key":"1618_CR207","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1166\/jbt.2018.1905","volume":"8","author":"M Ye","year":"2018","unstructured":"Ye M, Chen Y, Xie J, Yu M, Shi P, Xu W, Gui Z, Liu X (2018) miRNA-140-5p play an important role of Parkinson\u2019s disease development. J Biomater Tissue Eng 8(11):1566\u20131572","journal-title":"J Biomater Tissue Eng"},{"key":"1618_CR208","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.omto.2021.12.005","volume":"24","author":"M Ye","year":"2022","unstructured":"Ye M, Wang J, Pan S, Zheng L, Wang Z-W, Zhu X (2022) Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. Mol Ther Oncolytics 24:101\u2013113","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"1618_CR209","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/s41598-022-06539-3","volume":"12","author":"M Yousefi","year":"2022","unstructured":"Yousefi M, Peymani M, Ghaedi K, Irani S, Etemadifar M (2022) Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease. Sci Rep 12(1):2569. https:\/\/doi.org\/10.1038\/s41598-022-06539-3","journal-title":"Sci Rep"},{"issue":"7","key":"1618_CR210","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s11011-022-01038-w","volume":"37","author":"X Yuan","year":"2022","unstructured":"Yuan X, Wu Y, Lu L, Feng J (2022) Long noncoding RNA SNHG14 knockdown exerts a neuroprotective role in MPP(+)-induced Parkinson\u2019s disease cell model through mediating miR-135b-5p\/KPNA4 axis. Metab Brain Dis 37(7):2363\u20132373. https:\/\/doi.org\/10.1007\/s11011-022-01038-w","journal-title":"Metab Brain Dis"},{"key":"1618_CR211","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jocn.2019.04.004","volume":"65","author":"R Zeng","year":"2019","unstructured":"Zeng R, Luo DX, Li HP, Zhang QS, Lei SS, Chen JH (2019) Microrna-135b alleviates MPP(+)-mediated Parkinson\u2019s disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis. J Clin Neurosci 65:125\u2013133. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.004","journal-title":"J Clin Neurosci"},{"issue":"23\u201324","key":"1618_CR212","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1089\/hum.2020.106","volume":"31","author":"K Zhai","year":"2020","unstructured":"Zhai K, Liu B, Gao L (2020) Long-noncoding RNA TUG1 promotes Parkinson\u2019s disease via modulating miR-152-3p\/PTEN pathway. Hum Gene Ther 31(23\u201324):1274\u20131287. https:\/\/doi.org\/10.1089\/hum.2020.106","journal-title":"Hum Gene Ther"},{"key":"1618_CR226","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00170","volume":"11","author":"X Zhang","year":"2017","unstructured":"Zhang X, Yang R, Hu BL, Lu P, Zhou LL, He ZY, Wu HM, Zhu JH (2017) Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for Parkinson\u2019s disease. Front Cell Neurosci 11:170. https:\/\/doi.org\/10.3389\/fncel.2017.00170","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"1618_CR230","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bph.14091","volume":"175","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Chu SF, Wang SS, Jiang YN, Gao Y, Yang PF, Ai QD, Chen NH (2018) RTP801 is a critical factor in the neurodegeneration process of A53T alpha-synuclein in a mouse model of Parkinson\u2019s disease under chronic restraint stress. Br J Pharmacol 175(4):590\u2013605. https:\/\/doi.org\/10.1111\/bph.14091","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1618_CR218","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbrc.2019.08.140","volume":"519","author":"J Zhang","year":"2019","unstructured":"Zhang J, Dongwei Z, Zhang Z, Xinhui Q, Kunwang B, Guohui L, Jian D (2019a) miR-let-7a suppresses alpha-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson\u2019s disease. Biochem Biophys Res Commun 519(4):740\u2013746. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.140","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1618_CR219","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s13311-021-01130-6","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhao M, Yan R, Liu J, Maddila S, Junn E, Mouradian MM (2021b) Microrna-7 protects against neurodegeneration induced by alpha-synuclein preformed fibrils in the mouse brain. Neurotherapeutics 18(4):2529\u20132540. https:\/\/doi.org\/10.1007\/s13311-021-01130-6","journal-title":"Neurotherapeutics"},{"issue":"5","key":"1618_CR214","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.18632\/aging.102636","volume":"12","author":"G Zhang","year":"2020","unstructured":"Zhang G, Chen L, Liu J, Jin Y, Lin Z, Du S, Fu Z, Chen T, Qin Y, Sui F, Jiang Y (2020a) HIF-1alpha\/microRNA-128-3p axis protects hippocampal neurons from apoptosis via the Axin1-mediated Wnt\/beta-catenin signaling pathway in Parkinson\u2019s disease models. Aging (Albany NY) 12(5):4067\u20134081. https:\/\/doi.org\/10.18632\/aging.102636","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1618_CR220","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/26895293.2020.1741453","volume":"13","author":"L-w Zhang","year":"2020","unstructured":"Zhang L-w, Zhang J, Wang K, Wang R-b (2020b) Serum microRNA-30c-5p and microRNA-373 expressions as potential biomarkers for Parkinson\u2019s disease. All Life 13(1):194\u2013200. https:\/\/doi.org\/10.1080\/26895293.2020.1741453","journal-title":"All Life"},{"key":"1618_CR222","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuro.2020.02.004","volume":"78","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang J, Liu Q, Xiao Z, Dai Q (2020c) Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p\/MAPK1 axis. Neurotoxicology 78:29\u201335. https:\/\/doi.org\/10.1016\/j.neuro.2020.02.004","journal-title":"Neurotoxicology"},{"issue":"10","key":"1618_CR216","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22867","volume":"35","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang Z, Hu K, Liu H (2021a) Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson\u2019s disease model by targeting the miR-425-5p\/TRAF5\/NF-\u03baB axis. J Biochem Mol Toxicol 35(10):e22867. https:\/\/doi.org\/10.1002\/jbt.22867","journal-title":"J Biochem Mol Toxicol"},{"issue":"21","key":"1618_CR223","doi-asserted-by":"publisher","first-page":"9264","DOI":"10.18632\/aging.102330","volume":"11","author":"LM Zhang","year":"2019","unstructured":"Zhang LM, Wang MH, Yang HC, Tian T, Sun GF, Ji YF, Hu WT, Liu X, Wang JP, Lu H (2019b) Dopaminergic neuron injury in Parkinson\u2019s disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b\/ alpha-synuclein pathway. Aging (Albany NY) 11(21):9264\u20139279. https:\/\/doi.org\/10.18632\/aging.102330","journal-title":"Aging (Albany NY)"},{"key":"1618_CR224","doi-asserted-by":"publisher","DOI":"10.1515\/jib-2019-0027","author":"P Zhang","year":"2019","unstructured":"Zhang P, Wu W, Chen Q, Chen M (2019c) Non-coding RNAs and their integrated networks. J Integr Bioinform. https:\/\/doi.org\/10.1515\/jib-2019-0027","journal-title":"J Integr Bioinform"},{"issue":"2","key":"1618_CR228","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12031-019-01349-1","volume":"69","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xu W, Nan S, Chang M, Fan J (2019d) Microrna-326 inhibits apoptosis and promotes proliferation of dopaminergic neurons in Parkinson\u2019s disease through suppression of KLK7-mediated MAPK signaling pathway. J Mol Neurosci 69(2):197\u2013214. https:\/\/doi.org\/10.1007\/s12031-019-01349-1","journal-title":"J Mol Neurosci"},{"issue":"7","key":"1618_CR227","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s11064-020-03035-w","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xia Q, Lin J (2020d) LncRNA H19 attenuates apoptosis in MPTP-induced Parkinson\u2019s disease through regulating miR-585-3p\/PIK3R3. Neurochem Res 45(7):1700\u20131710. https:\/\/doi.org\/10.1007\/s11064-020-03035-w","journal-title":"Neurochem Res"},{"key":"1618_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.644507","volume":"15","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chen X, Chang M, Jiao B (2021c) MiR-30c-5p\/ATG5 axis regulates the progression of Parkinson\u2019s disease. Front Cell Neurosci 15:644507. https:\/\/doi.org\/10.3389\/fncel.2021.644507","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"1618_CR225","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10571-020-00946-8","volume":"41","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Huang XM, Liao JX, Dong YK, Zhu JL, He CC, Huang J, Tang YW, Wu D, Tian JY (2021d) LncRNA HOTAIR promotes neuronal damage through facilitating NLRP3 mediated-pyroptosis activation in Parkinson\u2019s disease via regulation of miR-326\/ELAVL1 axis. Cell Mol Neurobiol 41(8):1773\u20131786. https:\/\/doi.org\/10.1007\/s10571-020-00946-8","journal-title":"Cell Mol Neurobiol"},{"key":"1618_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104588","volume":"99","author":"F Zhang","year":"2022","unstructured":"Zhang F, Yao Y, Miao N, Wang N, Xu X, Yang C (2022a) Neuroprotective effects of microRNA 124 in Parkinson\u2019s disease mice. Arch Gerontol Geriatr 99:104588. https:\/\/doi.org\/10.1016\/j.archger.2021.104588","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"1618_CR215","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s12640-022-00525-3","volume":"40","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang C, Zhang X (2022b) Circular RNA hsa_circ_0004381 promotes neuronal injury in Parkinson\u2019s disease cell model by miR-185-5p\/RAC1 axis. Neurotox Res 40(4):1007\u20131019. https:\/\/doi.org\/10.1007\/s12640-022-00525-3","journal-title":"Neurotox Res"},{"key":"1618_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070811","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yao L, Zheng Z, Koc S, Lu G (2022c) The role of non-coding RNAs in the pathogenesis of Parkinson\u2019s disease: recent advancement. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15070811","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"1618_CR229","doi-asserted-by":"publisher","first-page":"315","DOI":"10.17219\/acem\/154658","volume":"32","author":"YJ Zhang","year":"2023","unstructured":"Zhang YJ, Zhu WK, Qi FY, Che FY (2023) CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p\/STAT3\/NLRP3 signaling pathway in Parkinson\u2019s disease. Adv Clin Exp Med 32(3):315\u2013329. https:\/\/doi.org\/10.17219\/acem\/154658","journal-title":"Adv Clin Exp Med"},{"key":"1618_CR231","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.17179\/excli2020-2286","volume":"19","author":"J Zhao","year":"2020","unstructured":"Zhao J, Li H, Chang N (2020a) LncRNA HOTAIR promotes MPP+-induced neuronal injury in Parkinson\u2019s disease by regulating the miR-874-5p\/ATG10 axis. EXCLI J 19:1141\u20131153. https:\/\/doi.org\/10.17179\/excli2020-2286","journal-title":"EXCLI J"},{"issue":"13","key":"1618_CR232","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/WNR.0000000000001494","volume":"31","author":"J Zhao","year":"2020","unstructured":"Zhao J, Yang M, Li Q, Pei X, Zhu X (2020b) Mir-132-5p regulates apoptosis and autophagy in MPTP model of Parkinson\u2019s disease by targeting ULK1. NeuroReport 31(13):959\u2013965. https:\/\/doi.org\/10.1097\/WNR.0000000000001494","journal-title":"NeuroReport"},{"issue":"3","key":"1618_CR233","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/kjm2.12485","volume":"38","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Xie Y, Yao WY, Wang YY, Song N (2022) Long non-coding RNA Opa interacting protein 5-antisense RNA 1 promotes mitochondrial autophagy and protects SH-SY5Y cells from 1-methyl-4-phenylpyridine-induced damage by binding to microRNA-137 and upregulating NIX. Kaohsiung J Med Sci 38(3):207\u2013217. https:\/\/doi.org\/10.1002\/kjm2.12485","journal-title":"Kaohsiung J Med Sci"},{"key":"1618_CR235","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.684289","volume":"13","author":"L Zhong","year":"2021","unstructured":"Zhong L, Ju K, Chen A, Cao H (2021) Circulating circRNAs panel acts as a biomarker for the early diagnosis and severity of Parkinson\u2019s disease. Front Aging Neurosci 13:684289. https:\/\/doi.org\/10.3389\/fnagi.2021.684289","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1618_CR234","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1007\/s12010-023-04740-2","volume":"196","author":"C Zhong","year":"2024","unstructured":"Zhong C, Zhang Q, Bao H, Li Y, Nie C (2024) Hsa_circ_0054220 upregulates HMGA1 by the competitive RNA pattern to promote neural impairment in MPTP model of Parkinson\u2019s disease. Appl Biochem Biotechnol 196(7):4008\u20134023. https:\/\/doi.org\/10.1007\/s12010-023-04740-2","journal-title":"Appl Biochem Biotechnol"},{"issue":"5","key":"1618_CR237","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1159\/000495872","volume":"51","author":"L Zhou","year":"2018","unstructured":"Zhou L, Yang L, Li YJ, Mei R, Yu HL, Gong Y, Du MY, Wang F (2018a) MicroRNA-128 protects dopamine neurons from apoptosis and upregulates the expression of excitatory amino acid transporter 4 in Parkinson\u2019s disease by binding to AXIN1. Cell Physiol Biochem 51(5):2275\u20132289. https:\/\/doi.org\/10.1159\/000495872","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"1618_CR244","doi-asserted-by":"publisher","first-page":"8550","DOI":"10.1007\/s12035-018-1005-0","volume":"55","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zhu J, Lv Y, Song C, Ding J, Xiao M, Lu M, Hu G (2018b) Kir6.2 deficiency promotes mesencephalic neural precursor cell differentiation via regulating miR-133b\/GDNF in a Parkinson\u2019s disease mouse model. Mol Neurobiol 55(11):8550\u20138562. https:\/\/doi.org\/10.1007\/s12035-018-1005-0","journal-title":"Mol Neurobiol"},{"issue":"15","key":"1618_CR242","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2217\/epi-2019-0222","volume":"11","author":"T Zhou","year":"2019","unstructured":"Zhou T, Lin D, Chen Y, Peng S, Jing X, Lei M, Tao E, Liang Y (2019) Alpha-synuclein accumulation in SH-SY5Y cell impairs autophagy in microglia by exosomes overloading miR-19a-3p. Epigenomics 11(15):1661\u20131677. https:\/\/doi.org\/10.2217\/epi-2019-0222","journal-title":"Epigenomics"},{"key":"1618_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105197","volume":"160","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhao Y, Li Z, Zhu M, Wang Z, Li Y, Xu T, Feng D, Zhang S, Tang F, Yao J (2020a) MiR-103a-3p regulates mitophagy in Parkinson\u2019s disease through Parkin\/Ambra1 signaling. Pharmacol Res 160:105197. https:\/\/doi.org\/10.1016\/j.phrs.2020.105197","journal-title":"Pharmacol Res"},{"issue":"9","key":"1618_CR239","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/iub.2344","volume":"72","author":"S Zhou","year":"2020","unstructured":"Zhou S, Zhang D, Guo J, Chen Z, Chen Y, Zhang J (2020b) Long non-coding RNA NORAD functions as a microRNA-204-5p sponge to repress the progression of Parkinson\u2019s disease in vitro by increasing the solute carrier family 5 member 3 expression. IUBMB Life 72(9):2045\u20132055. https:\/\/doi.org\/10.1002\/iub.2344","journal-title":"IUBMB Life"},{"key":"1618_CR240","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fnins.2020.00930","volume":"14","author":"S Zhou","year":"2020","unstructured":"Zhou S, Zhang D, Guo J, Zhang J, Chen Y (2020c) Knockdown of SNHG14 alleviates MPP(+)-induced injury in the cell model of Parkinson\u2019s disease by targeting the miR-214-3p\/KLF4 axis. Front Neurosci 14:930. https:\/\/doi.org\/10.3389\/fnins.2020.00930","journal-title":"Front Neurosci"},{"issue":"3","key":"1618_CR238","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.18632\/aging.202378","volume":"13","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zhang MM, Liu M, Tan ZG, Qin QL, Jiang YG (2021) LncRNA XIST sponges miR-199a-3p to modulate the Sp1\/LRRK2 signal pathway to accelerate Parkinson\u2019s disease progression. Aging (Albany NY) 13(3):4115\u20134137. https:\/\/doi.org\/10.18632\/aging.202378","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"1618_CR241","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s11064-022-03795-7","volume":"48","author":"S Zhou","year":"2023","unstructured":"Zhou S, Zhou X, Jiang Z, Ma J, Li Y, Qian Z, Li H (2023a) The mechanism of SNHG8\/MicroRNA-421-3p\/sorting nexin 8 axis on dopaminergic neurons in substantia nigra in a mouse model of Parkinson\u2019s disease. Neurochem Res 48(3):942\u2013955. https:\/\/doi.org\/10.1007\/s11064-022-03795-7","journal-title":"Neurochem Res"},{"issue":"9","key":"1618_CR243","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1080\/15548627.2023.2196889","volume":"19","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liu Y, Kang Z, Yao H, Song N, Wang M, Song C, Zhang K, Ding J, Tang J, Hu G, Lu M (2023b) Circeps15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy. Autophagy 19(9):2520\u20132537. https:\/\/doi.org\/10.1080\/15548627.2023.2196889","journal-title":"Autophagy"},{"key":"1618_CR245","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2018.07.023","volume":"835","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wang S, Liang Y, Xu X (2018) Inhibition of microRNA-505 suppressed MPP+ -induced cytotoxicity of SHSY5Y cells in an in vitro Parkinson\u2019s disease model. Eur J Pharmacol 835:11\u201318. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.023","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1618_CR246","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12035-021-02619-z","volume":"59","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Huang P, Sun R, Li X, Li W, Gong W (2022) A novel long-noncoding RNA LncZFAS1 prevents MPP(+)-induced neuroinflammation through MIB1 activation. Mol Neurobiol 59(2):778\u2013799. https:\/\/doi.org\/10.1007\/s12035-021-02619-z","journal-title":"Mol Neurobiol"},{"key":"1618_CR247","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010090","author":"VD Zingale","year":"2021","unstructured":"Zingale VD, Gugliandolo A, Mazzon E (2021) MiR-155: an important regulator of neuroinflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23010090","journal-title":"Int J Mol Sci"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01618-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:26:54Z","timestamp":1767936414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01618-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":244,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01618-1","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"7"}}